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ABSTRACT 
 
Maintaining genome integrity is indispensible for cells to prevent and 
limit accruement of deleterious mutations and to promote viable cell 
growth and proliferation.  Cells possess a myriad of mechanisms to 
detect, prevent and repair incurred cellular damage.  Here we discuss 
various proteins and their accompanying cellular pathways that promote 
genome stability.  We first investigate the NEDD8 protein and its role 
in promoting homologous recombination repair via multiple Cullin E3 
ubiquitin ligases.  We provide specific mechanisms through which, 
UBE2M, an E2 conjugating enzyme, neddylates various Cullin ligases to 
render them catalytically active to degrade their substrates by the 
proteasome.  We show that CUL1, CUL2 and CUL4 are important in 
regulating various steps in the DNA damage response.  Our data 
indicates that UBE2M and the neddylation pathway are important for 
genome stability.  Our second topic discusses the role of the USP1-
UAF1 deubiquitinating enzyme in promoting homologous recombination.  
We show that USP1-UAF1 interact with and stabilize RAD51AP1 (RAD51-
Associated Protein 1).  RAD51AP1 has previously been reported to 
promote homologous recombination by facilitating recombinase activity 
of RAD51, an essential protein involved in homologous recombination 
repair.  We show that USP1, UAF1 and RAD51AP1 depletion leads to 
genome instability.  Our data demonstrates the importance of these 
proteins in promoting genome integrity via homologous recombination. 
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CHAPTER ONE: INTRODUCTION TO NEDD8 AND CULLIN RING LIGASES 
 
NEDD8 and the Neddylation Pathway 
Ubiquitin is an essential protein involved in post-translational 
modifications in eukaryotes required for many cellular processes [1,2]. 
NEDD8 is an ubiquitin-like molecule (UBL) that regulates many similar 
cellular pathways, similar to ubiquitination, in eukaryotic cells such 
as histone and Cullin Ring Ligase neddylation involved in the DNA 
damage response (DDR), transcriptional regulation, signal transduction 
and cell cycle progression [2,3,4,5].  Among the ubiquitin like 
molecules (SUMO1, ATG8, ISG15, and others), NEDD8, a 76 amino acid 
protein, is most similar to ubiquitin by sharing approximately 57% 
sequence similarity [6,7].  Moreover, akin to ubiquitin, NEDD8 follows 
a similar pathway of activation called neddylation.   
 
Neddylation Cascade – NEDD8 Processing and Substrate Activation 
The NEDD8 pathway consists of an E1 activating, E2 conjugating and E3 
ligase enzymes.  Neddylation leads to a covalent bond created between 
the NEDD8 molecule, at a conserved carboxy-terminal glycine (Gly 76) 
residue, and its substrate protein.  NEDD8 is covalently linked to its 
target substrates at a lysine residue via an isopeptide bond [2].  
NEDD8 processing begins with cleavage of its C-terminal tail to 
prepare its Gly 76 residue for isopeptide bond formation by a protein 
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UCHL3 (Ubiquitin C-terminal tail hydrolase), or SENP8 [2,8].  Once the 
C-terminal tail of NEDD8 is processed, exposing its Gly 76 residue for 
interaction, an E1 activating enzyme catalyzes NEDD8 adenylation and 
subsequent thioester bond formation between the E1 (NAE1-UBA1) and 
NEDD8 [9,10].  The E1 activating enzyme requires ATP to bind to Gly 76 
to form an adenylated NEDD8, which can then be utilized to form the 
thioester bond between the E1 and NEDD8, releasing a free AMP molecule. 
The charged E1 is then prepared to transfer the bound NEDD8 molecule 
to an E2 conjugating enzyme.  The E2 enzyme (UBE2M/Ubc12, UBE2F) 
accepts the NEDD8 molecule forming another thioester peptide bond.  At 
this point the charged E2 enzyme will interact with an E3 ligase, 
which promotes the E3 ligase neddylation and activation (Figure 1).   
 
Figure 1.  Overview of the neddylation pathway.  NEDD8 is first 
processed by UBCHL3, which cleaves the C-terminal residues to expose 
the Gly 76 residue.  An E1 activating enzyme then adenylates NEDD8 and 
forms a thioester bond to NEDD8.  An E2 conjugating enzyme then 
accepts the NEDD8 molecule and binds to and neddylates an E3 ligase 
thus activating the E3 complex (adapted from Mergner et al., 2014 [6]).   
 
 
The Cullin E3 RING ubiquitin ligases (CRL) are the most well studied 
E3 enzymes and will suffice as a model to further explain the 
neddylation pathway.  RBX1 (RING-box Protein 1), which is a component 
of Cullin E3 RING ubiquitin ligases, interacts with UBE2M/Ubc12 to 
N8 
E1 E2 E3 
N8 N8 N8 
E3 E2 E1 
E1 
!"#$%&'
NEDD8 
ATP 
AMP + PPi 
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form a pseudo-E3 NEDD8 ligase, which neddylates the Cullin scaffold 
[2,6].  Neddylation of the Cullin scaffold protein results in 
activation of the CRL, which can now load various E2 ubiquitin- 
conjugating enzymes and ubiquitinate the CRL’s substrates.  Cullin 
RING ligases will be covered more extensively in the following section. 
 
Cullin RING Ligases 
Cullin RING ligases are E3 ubiquitin ligases that are part of the 
ubiquitin-proteasome system (UPS) and regulate a vast quantity of 
cellular pathways by marking their substrates for proteasomal 
degradation.  As in the neddylation pathway, the UPS forms an E1, E2 
and E3 cascade, which contain E1 ubiquitin activating, E2 ubiquitin 
conjugating, and E3 ubiquitin ligase enzymes [11].   
 
Cullin (CUL) RING ligases form modular E3 ubiquitin ligases consisting 
of multiple subunits: RING domain, adaptor, and substrate recognition 
proteins (these components will be discussed below).  CRLs are RING 
(Really Interesting New Gene) E3 ligases, which enable an E2 
ubiquitin-conjugating enzyme to load onto the CRL through an RBX 
protein (RBX1: CUL1-CUL4, CUL7; RBX2: CUL5) [12] (Figure 2).   
 
The RBX RING domain is essential to the function of the CRL.  RING 
domains employ two Zn2+ ions contained within eight residues, mostly 
histidine and cysteine, to facilitate binding of E2 conjugating 
enzymes to the CRL [13,14].  E2 enzymes interact with the RING domain 
through conserved UBC (ubiquitin conjugating) domains containing a 
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catalytic cysteine residue.  E2 enzymes may also possess various 
insertions within the UBC domain, which provides differing functions 
to the E2.  These variations in the E2s allow them to generate diverse 
ubiquitin chain linkages (i.e. monoubiquitination, multi-
monoubiquitination, or polyubiquitination), thus the E3s, to which 
they bind, exhibit specificity in their substrate proteins for 
ubiquitination by the UPS [13,14].  In E3s containing RING domains, 
the RING domain itself does not directly bind ubiquitin from the E2; 
instead, it acts as a scaffold protein to promote E2 binding and 
subsequent release of the ubiquitin molecule to its substrate [14].  
It has also been suggested that the RING domain’s interaction with the 
E2 may promote the release of ubiquitin from the E2 to its substrate 
protein [15].  It has been proposed that E2 binding to RING domain 
facilitates a closed E2 structure, thus advocating the release of the 
bound ubiquitin molecule [13]. 
 
CRLs also possess an adaptor protein, which forms a mediator between 
the Cullin scaffold and the substrate of the CRL.  The Cullin scaffold 
protein in each CRL provides the core unit of the CRL and provides a 
means to bring the RING domain (C-terminus of Cullin scaffold) into 
proximity of the CRL’s substrate (N-terminus of Cullin scaffold) for 
transfer of ubiquitin from the E2 to the substrate [12,16].  Each 
Cullin protein contains specificity for its adaptor protein through 
triple repeat, N-terminal α-helical structures (Cullin repeats) and 
within these repeats there are five α-helices [16,17].  The second and 
fifth α-helices are responsible for interaction with the CRL substrate 
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recognition protein, whereby the primary sequence of these α-helices 
determines which substrate recognition proteins can be loaded onto the 
CRL [16].  The adaptor proteins, once loaded onto the CRL, will 
specifically bind an appropriate substrate recognition protein 
determined by binding motifs within the adaptor protein.  The adaptor 
protein employed is designated by the Cullin scaffold protein, whereby 
CUL1 and CUL7 interact with Skp1, CUL2 and CUL5 interact with Elongin 
B and C, CUL3 interacts with BTB and lastly CUL4A and CUL4B interact 
with DDB1 [12,16].  The binding of various adaptor proteins to the CRL 
provides increasing specificity for the substrates of each CRL.  To 
further increase CRL substrate specificity, substrate recognition 
proteins are utilized. 
 
Figure 2.  Cullin RING ligase structure diagram.  CRLs are comprised 
of a Cullin (CUL 1-5, 7) scaffold protein, which provides the core 
unit of the CRL.  The scaffold protein binds the RING domain to its C-
terminus and the substrate recognition domain via its N-terminus.  The 
C-terminal RING domain allows for interaction of the CRL to an 
ubiquitin E2 conjugating enzyme via a RING-box protein.  The N-
terminal substrate recognition domain is comprised of an adaptor 
protein, which recruits a substrate recognition protein responsible 
for binding the CRL’s substrate to promote its ubiquitination.  NEDD8 
(depicted as N8) binds to the Cullin scaffold and activates the RING 
ligase catalytic activity (adapted from Lydeard et al., 2013 [11]). 
!"##$%&
'()*&
+,-&
./012,3&
4"5623027&
378,9%$:,%&
4"5623027&
;<&
)=&
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Each CRL recruits specific substrate recognition proteins (SRP) via 
the CRL adaptor protein.  The SRP is responsible for selectively 
binding a specific substrate to the CRL to allow transfer of the 
ubiquitin molecule from the charged, bound E2.  Each CRL binds a 
designated substrate recognition protein where CUL1 binds F-box, CUL2 
binds VHL, CUL3 binds BTB, CUL4A and CUL4B bind DCAF, CUL5 binds SOCS-
box and CUL7 binds FBW8 [12,16]. 
 
The Role of NEDD8 in Cancer Biology 
In order for cells to maintain homeostasis it is imperative for them 
to possess the capability to regulate many cellular processes.  Cells 
must be able to regulate cell cycle progression, signal transduction, 
transcription, initiate required programmed cell death and maintain 
the integrity of the genome.  Cancerous cells seek to exploit these 
very pathways, which are utilized to maintain a healthy cell and 
dysregulation of any of these pathways may lead to cancer formation.  
NEDD8 plays an important role in regulating these pathways via the UPS, 
which works through activation of Cullin E3 RING ligases.  Cullin 
scaffold neddylation promotes dissociation of CAND1 (Cullin-associated 
neddylation-dissociated protein 1); the dissociation of CAND1 from the 
CRL, causes the CRL to form an open conformation and thus permits an 
RBX protein and an adaptor protein to associate with the CRL, 
therefore CAND1 association sequesters CRLs from achieving an active 
enzymatic status [16,17,18].  Neddylating and activating CRL for their 
catalytic activity is essential for a functional UPS to regulate 
cellular process.  CRLs promote UPS activity by marking various 
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proteins for proteasomal degradation.  CRL substrates include: CUL1 
degrades p21, p27, IκBα, Cyclins D/E, Cdc25A and c-Myc, CUL2 degrades 
HIF-1α, CUL3 degrades NRF2, and CUL4 degrades p21, p27 and CDT1 (CUL5 
and CUL7 omitted as they are out of scope of the discussion) [18,19].  
To briefly mention, as this is not the focus of the discussion, NEDD8 
regulates various protein independent of CRLs.  Such proteins include, 
MDM2 neddylation of p53 and TAp73 for their transactivations and the 
neddylation of BCA3 (an NF-κB inhibitor) [2,4,14,19].   
 
NEDD8 is also involved in the neddylation of histones H2A and H4, 
which provides an early initiator in the DNA damage signaling cascade.  
RNF111, an E3 ubiquitin ligase, has been shown to polyneddylate 
histone H4.  This polyneddylation of H4 provides a docking platform to 
recruit RNF168 and perpetuating the damage response by recruiting 
downstream repair factors (RAP80, BRCA1 and 53BP1) [1].  In 
concordance with UBE2M/Ubc12 being one of the two E2 NEDD8 conjugating 
enzymes, RNF111 was shown to interact with UBE2M/Ubc12 via its RING 
domain [1].  As previously mentioned, NEDD8 is also involved in 
histone H2A and γH2AX neddylation and drives a negative regulation of 
the ubiquitination cascade.  By downregulating histone H2A and γH2AX 
ubiquitination the DNA damage response (DDR) is ablated, thus 
providing a mechanism for controlling the DDR.  It has been shown that 
polyneddylation of histones H2A and γH2AX prevents polyubiquitination 
of these histones, ergo reducing the damage response cascade.  It was 
then shown by the same study that as histone ubiquitination increased 
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histone neddylation decreased and vice versa [3].  As evidenced by the 
vast repertoire of proteins regulated by NEDD8, it is easy to see how 
inactivating the neddylation pathway would be an advantageous pathway 
to disrupt in treating cancer cells. 
 
Targeting the NEDD8 pathway in cancer 
The NEDD8 pathway regulates numerous cellular processes from cell 
cycle progression to transcription and replication.  Since many 
pathways are implicated in the NEDD8 pathway, a molecular inhibitor of 
NEDD8 would be quite propitious in a chemotherapeutic approach to 
fighting cancer.  With a mechanism of inhibition of NEDD8, it could be 
used to combat various cancer types due to the pathway’s broad range 
of applications and those specifically regulated by CRLs.  CRLs target 
a myriad of different substrate proteins for proteasomal degradation 
(approximately 20% of intracellular proteins are targeted for 
degradation by CRL), thus inhibiting the NEDD8 pathway allows for a 
vast inhibitory effect on these pathways regulated by the Cullins [18].  
To exemplify this claim, p21, p27 and CDC25A are found to be 
downregulated in various cancers and are also substrates of CRLs, 
specifically CRL1 and CRL4.  By inhibiting the NEDD8 pathway and 
subsequently CRL catalysis and ubiquitination of these substrates, 
cells can promote cell cycle arrest and proapoptotic pathways, which 
are mechanisms thwarted in cancer cells [16,18].  Another important 
role of CRL in promoting genome stability is the ability to regulate 
replication, licensing factor CDT1.  CDT1 is responsible for ensuring 
replication is only initiated once per cell cycle [20].  CDT1 is 
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targeted for proteolysis in G2/M by CRL1 and CRL4.  When CDT1 evades 
proteasomal degradation its stabilization leads to rereplication, 
which ultimately results in genome instability [16,20].  Inhibiting 
CRLs that degrade CDT1 promote genome rereplication, genome 
instability and sensitize cells to various DNA damaging agents, 
therefore causing these cells to undergo apoptosis, which provides a 
valid rationale, along with the previous example (stabilizing 
checkpoint proteins targeted by CRLs that are overexpressed in cancer 
cells), to suppress CRL activity via inhibition of the NEDD8 pathway 
[21]. 
 
MLN4924: a small molecule inhibitor 
MLN4924 is a small molecule, selective inhibitor of NAE1 currently in 
phase 1 clinical trials [21,22].  In short, MLN4924 retards CRL 
activity, and stabilization of CRL substrates follows, by inhibiting 
NAE1 by forming a NEDD8-NAE1 adduct (this will be described in greater 
detail below).  This stabilization of CRL substrates induces genomic 
instability, apoptosis, and dysregulated cell cycle progression 
resulting in decreased cancer cell proliferation [16,20,21]. 
 
As mentioned earlier, MLN4924 inhibits the NEDD8 pathway by forming an 
adduct with NAE1, thus inhibiting NAE1 activity and suppressing the 
neddylation cascade.  The formal mechanism is as follows and is 
depicted below (Figure 3).  NEDD8 is first processed by UBCHL3 and 
adenylated (NEDD8-AMP) by NAE1 in an ATP-dependent manner.  Next, 
NAE1’s catalytic cysteine binds to NEDD8 via a nucleophilic attack, 
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thus displacing AMP and forming a NEDD8-NAE1 thioester bond.  NAE1’s 
AMP nucleotide binding pocket then becomes available for MLN4924 
binding where it is positioned to interact with NEDD8 to displace, via 
another nuleophilic attack, the NEDD8-NAE1 thioester bond and forming 
a NEDD8-MLN4924 adduct through its sulfamate group (H2NO3S) [22].  
 
Figure 3.  The mechanistic action of MLN4924 in inhibiting NAE1.  
Briefly, NEDD8 is adenylated by NAE1, whereby NAE1 catalyzes a 
thioester bond formation with NEDD8.  NEDD8 undergoes a nucleophilic 
attack by MLN4924 and forms a NEDD8-MLN4924 adduct in the catalytic 
pocket of NAE1 (adapted from Brownell et al., 2010 [22]). 
 
An Overview of Homologous Recombination DNA Repair 
Homologous recombination (HR) is an integral repair pathway to detect 
and repair damaged DNA specific to double strand breaks (DSB) and 
interstrand crosslinks (ICL) (Figure 4).  The HR pathway is also 
N8 
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utilized in meiosis I for chromosomal segregation, preventing telomere 
decay, and reinitiating stalled replication forks [23-26].  The role 
of HR in genome maintenance and stability, however, will be the focus 
of this discussion.  HR is the transfer of genetic information shared 
between homologous chromosomal, allelic sequences [25].  DSBs pose a 
considerable threat on genome maintenance and stability and any such 
breaks that persist unresolved may eventually lead to chromosomal 
rearrangements, cell death or tumorigenesis [26].  Double strand 
breaks can be induced through various genotoxic elements such as 
exogenous (UV and γ-irradiation) and endogenous (cellular metabolites) 
DNA damage.  HR is considered an error-free repair mechanism by 
utilizing a homologous DNA sequence as a template strand to repair the 
DNA lesion.  In short, when a double strand break is encountered, the 
HR pathway is initiated, which leads to DNA 5’-end resection carried 
out by the MRN complex (MRE11, RAD50, and NBS1) and CtIP at the damage 
locus [28].  The 5’-end resection results in 3’-overhangs from which 
double Holliday junctions (HJ) can be formed between the damaged 
chromosome and the homologous, template chromosome.  Depending on the 
manner of the HJ resolution (horizontal versus vertical resolution), 
carried out by DNA resolvases GEN1 and the SLX1-SLX4 complex, leads to 
either a crossover or non-crossover product [27].  The HR repair 
pathway will be covered in greater detail in the following sections. 
 
The RAD51 Recombinase Regulates the HR Repair Pathway 
The HR pathway is heavily dependent on the recombinase RAD51 and as 
such is regulated through RAD51 activity, thus it is worthwhile to 
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discuss the regulation of RAD51.  RAD51 has an affinity for ssDNA, 
which becomes available in the DSB scenario when CtIP and the MRN 
complex complete the 5’-end resection.  One study showed that RPA 
(replication protein A) had a higher affinity for ssDNA than RAD51 
[29].  Further investigation showed that RPA reduces ssDNA secondary 
structure formation, which allows RAD51 to readily associate with 
ssDNA.  RPA facilitates RAD51 protein recruitment, alongside mediator 
proteins (ex. BRCA2), to ssDNA and in so doing RAD51 displaces RPA 
from the DNA [29,30].  BRCA2 is responsible for the loading of RAD51 
onto ssDNA, thus forming the RAD51 presynaptic filament and is the 
principle mediator of RAD51 in mammalian cells [25,30].  There exist 
RAD51 paralogues (RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3) that also 
promote RAD51 protein function in HR.  These RAD51 paralogues are 
responsible for RAD51 nucleofilament formation by recruiting RAD51 to 
sites of DNA damage and ssDNA bound by RPA [26,28,30]. 
 
There also exist negative regulators of RAD51 through which HR can be 
regulated.  HR may need to be inhibited when replication progression 
and genome repair lead to replication and genome instability.  In 
yeast there is an anti-recombinase called SRS2.  An SRS2 mammalian 
orthologue has not yet been discovered, but FBH1 (F-box DNA helicase 
1) is a prevailing candidate [30-32].  SRS2 functions to dissociate 
RAD51-bound ssDNA.  SRS2 promotes RAD51 nucleofilament disassembly, 
but its activity is countered by the mediator proteins’ interactions 
with RAD51, ergo, depending on the ratio of RAD51-mediator interaction 
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to RAD51-SRS2 interaction, HR will progress normally (RAD51-mediator 
dominant) or will be inhibited (RAD51-SRS2 dominant) [30]. 
 
ATR and ATM Kinases Propagate the DNA Damage Response 
HR repair pathway is initiated when double strand, DNA breaks are 
recognized by the cell.  To initiate HR, a DNA damage response, 
signaling cascade must be invoked.  The first step in HR, after 
encountering a DSB, is to halt cell cycle progression to allow the 
cell ample time to recruit the required repair factors to restore the 
genome and allow the cell to resume normal cell cycle progression.  
Two major proteins involved in the DNA damage response (DDR) are ATR 
(Ataxia telangiectasia and Rad3-related protein) and ATM (Ataxia 
telangiectasia mutated).  ATR and ATM are serine/threonine protein 
kinases responsible for phosphorylation of CHK1 and CHK2, respectively, 
however it should be noted that a means of crosstalk is present 
between ATR/ATM and CHK1/CHK2 activation [33,34,35].  ATR and ATM are 
known to promote cell cycle arrest at the G1 and G2/M checkpoints 
depending on when the DNA damage is discovered.  DSBs, specifically 
ssDNA coated with RPA, detected during G1-S promote ATR-dependent CHK1 
phosphorylation, while DSBs detected during S-phase potentiate the DDR 
by ATM-dependent CHK2 phosphorylation [33-35].  Detection of DSBs by 
ATR and ATM lead to various substrate phosphorylations that propagate 
the DDR signal transduction.  Lastly, when ATR and ATM are activated 
in response to DNA damage they phosphorylate histone variant γH2AX, 
BRCA1, MDM2, p53, MRN complex and Cdc25a [33].   
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Histone γH2AX and its Role in the DNA Damage Response 
Histone variant γH2AX is a critical player in the DDR and is 
phosphorylated by ATR and ATM in response to DNA damage.  Its 
phosphorylation is used as a biomarker to establish sites of DSBs and 
to propagate the damage response by recruiting downstream repair 
factors, which will be discussed now.  γH2AX is a histone variant of 
H2A and is evenly distributed throughout the genome and represents 
approximately 2-25% of H2A class histones.  Histone H2AX can be 
phosphorylated on serine 1 and ubiquitinated on lysine 119, 
interestingly however, upon DNA damage, H2AX is phosphorylated at 
serine 139, becoming γH2AX [36,37].  Serine 139 of H2AX is 
phosphorylated upon DNA damage, which leads to recruitment of 
downstream repair factors such as BRCA1, NBS1 (of the MRN complex), 
53BP1 and MDC1 [37].  γH2AX has also been shown to be polyubiquitinated 
in response to DNA damage, thus propagating DNA damage signaling 
through its polyubiquitination.  γH2AX polyubiquitination is dependent 
on RNF168 monoubiquitination, which then enables RNF8-mediated 
polybubiquitination of γH2AX [38].  Another proposed mechanism of γH2AX 
DNA damage signal transduction is carried out by its 
polyubiquitination, mediated by UBC13 and TIP60.  TIP60, a histone 
acetyltransferase, is responsible for γH2AX acetylation, which is 
required for UBC13 (found to be a binding partner of TIP60) to 
polyubiquitinate γH2AX, however it is not known at this time how this 
facilitates DNA repair, but is believed to recruit histone modifiers 
to the sites of DNA damage and facilitate DNA damage resolution [39]. 
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Figure 4.  The homologous recombination repair pathway.  Incurring DNA 
damage induces a DDR signaling cascade to halt the cell cycle and 
recruit DNA repair factors.  DNA damage elicits γH2AX phosphorylation 
by ATR/ATM, leading to recruitment and activation of the MRN complex.  
MRN with CtIP perform 5’-end resection, providing 3’-overhangs for RPA 
to bind to.  BRCA2 then mediates the recruitment of RAD51 to RPA 
coated ssDNA and RAD51 displaces RPA.  RAD51 performs a homology 
search to find the homologous chromosome to act as a template strand 
for HR.  Once the homologous chromosome is found DNA polymerases and 
ligases are recruited to the damaged chromosome.  Lastly, GEN1 and 
SLX1-SLX4 resolve the Holliday junctions and HR is complete (adapted 
from Li et al., 2008 and Smith et al., 2010 [26,34]).  
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CHAPTER TWO: INTRODUCTION TO FANCONI ANEMIA AND DEUBIQUITINATING 
ENZYMES 
 
Fanconi Anemia Repair Pathway 
Fanconi Anemia (FA) is an autosomal, recessive or X-linked disorder 
and patients afflicted with this disorder may exhibit one or more of 
the following clinical symptoms: congenital abnormalities, bone marrow 
failure, hypopigmentation and susceptibility to cancer [40,41].  The 
pathway is well known to govern the detection and resolution of 
interstrand crosslinks (ICL), however the mechanisms through which it 
works are not fully understood.  The FA pathway is active in many 
replication-dependent repair pathways, however it has been suggested 
it is the major repair pathway involved in resolving ICLs [40].  The 
FA pathway is thought to be the major repair pathway of ICLs due in 
part to FA patient cells being hypersensitized to DNA crosslinking 
agents such as cisplatin and mitomycin C [40-42].  To date, there are 
16 FA proteins (FANCA, B, C, D1, D2, E, F, G, I, J, L, M, N, O, P and 
Q) found to be mutated in FA patients and of these 16 proteins half of 
them make up what is known as the FA core complex (FANCA, B, C, E, F, 
G, L and M) [43].  The core complex is known to function as a multi-
subunit E3 ubiquitin ligase, which monoubiquitinates FANCD2/I 
heterodimer [42,44].  FANCD2 and FANCI are both phosphorylated by ATR 
and ATM and their phosphorylation leads to their monoubiquitination 
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and chromatin localization.  Upon IR induced damage, FANCD2 is 
phosphorylated by ATM and in the instance of detection of stalled 
replication forks due to ICLs ATR phosphorylates FANCD2 [45].  It 
should be noted that ATM is not required for FANCD2 monoubiquitination, 
however ATR-dependent phosphorylation of FANCD2 is indispensible for 
its monoubiquitination [46].  It turns out that the monoubiquitination 
of FANCD2 drives monoubiquitination of FANCI and vice versa [47].  
FANCD2 and FANCI monoubiquitination by the core complex causes the 
FANCD2/I heterodimer to localize to the chromatin, thus marking sites 
of DNA damage.  They then act as loading docks to recruit downstream 
repair factors such as BRCA2, FAN1 (Fanconi-associated nuclease 1) and 
SLX1-SLX4 [45,48].  Before the FANCD2/I heterodimer is 
monoubiquitinated, the core complex must recognize sites of stalled 
replication forks or ICLs.  The core complex contains two protein 
FANCM and FAAP24 (Fanconi Anemia-associated protein 24), that detect 
these DNA lesions.  FANCM is responsible for detecting stalled 
replication forks and causes reversal of the fork progression, while 
FAAP24 is able to bind ssDNA via its contained nuclease region [40].  
With these combined activities FANCM and FAAP24 recognize stalled 
replication forks and then recruit the FA core complex to the 
chromatin, thus monoubiquitinating FANCD2/I, which results in their 
translocation to the DNA damage site to recruit downstream repair 
factors. 
 
The FA pathway is utilized during synthesis to remove ICLs, repair the 
lesion and then continue and complete DNA synthesis.  The FA pathway 
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thus makes use of nucleotide excision repair (NER), translesion 
synthesis (TLS) and HR.  When an ICL is detected during DNA synthesis, 
FANCM and FAAP24 recruit the FA core complex to the DNA lesion and ATR 
and ATM phosphorylate FANCD2 and FANCI.  Their phosphorylation and the 
recruitment of the FA core complex to the chromatin facilitate FANCD2 
and FANCI monoubiquitination and translocation to the site of insult.  
FANCD2 then recruits various endonucleases (SLX1-SLX4, FAN1, ERCC1-XPF 
and MUS81-EME1) to induce nucleolytic cleavages to remove the ICL from 
one complementary DNA strand.  MUS81-EME1 induces the primary 
nucleolytic incision 3’ of the ICL, while ERCC1-XPF induces the 
secondary 5’ incision of the ICL [40,44].  It has also been shown in 
various studies that XPF colocalizes with FANCA at sites of DNA damage 
and that ERCC1-XPF cleavage drastically increases monoubiquitinated 
FANCD2 chromatin translocation and localization [49,50].  At this 
stage, TLS polymerases are recruited to bypass the ICL, as they are 
capable of replicating beyond the lesion while leaving the lesion 
intact [51].  Initiating TLS begins with monoubiquitination of PCNA 
(proliferating cell nuclear antigen), which recruits TLS polymerases 
and associated proteins to regulate polymerase switching (REV1, Pol ζ, 
Pol η, Pol ι and Pol κ) [44,52]. The nucleolytic cleavages, induced 
from the endonucleases, result in a DSB and the completion of TLS on 
the complementary strand allows for HR to be utilized to repair the 
DSB.  Finally, NER proteins are recruited to remove the final adduct 
from the ICL and synthesize DNA to fill the remaining gaps and DNA 
ligases terminate the gaps. 
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Figure 5.  The Fanconi Anemia repair pathway.  Detection of an ICL by 
FAAP24 and FANCM leads to FA core complex recruitment to the chromatin.  
ATR and ATM phosphorylate FANCD2/I and the core complex 
monoubiquitinates the FANCD2/I heteroduplex.  Upon monoubiquitination 
FANCD2/I translocate to the damaged chromatin and recruit 
endonucleases SLX1-SLX4, FAN1, ERCC1-XPF and MUS81-EME1 to excise the 
ICL.  Nucleolytic cleavage of the DNA allows for TLS polymerases to 
bypass the lesion and complete strand synthesis in one of the 
chromatids.  The excised DNA causes a DSB, whereby HR proteins are 
recruited such as BRCA2 and RAD51 (not depicted, see Figure 4) to 
repair the DSB.  Finally, NER proteins (DNA polymerases and ligases) 
are recruited to remove the ICL adduct and fill gaps in the DNA.  
Lastly, USP1-UAF1 deubiquitinate FANCD2/I and the FA pathway and DNA 
damage resolution is complete (adapted from Kim et al., 2012 [44]). 
 
Finally, the deubiquitinating enzyme complex USP1-UAF1 deubiquitinates 
FANCD2/I, which halts the FA repair pathway and the ICL is repaired 
[40,44] (Figure 5). 
 
Deubiquitinating Enzymes 
Deubiquitinating enzymes (DUBs) are responsible for removing 
monoubiquitin or polyubiquitin chains from substrate proteins.  There 
are approximately 100 DUBs in humans divided amongst five families, 
which are dictated by their mechanisms of action.  The five families 
are ubiquitin-specific proteases (USPs), ovarian tumor proteases 
(OTUs), ubiquitin C-terminal hydrolases (UCHs), Josephins and zinc-
dependent metalloproteases (JAMMs) [53-55].  DUBs are involved in the 
ubiquitin-proteasome system (UPS), where their role is to counteract 
the process of substrate ubiquitination with either ubiquitin or 
ubiquitin-like molecules.  DUBs possess a high level of specificity 
for their substrate and are called cryptic proteases.  That is to say, 
the catalytic activity of DUBs is stunted by its inactive conformation 
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(i.e. not bound to a substrate protein).  Upon substrate interaction, 
the DUB acquires its catalytically active conformation and thus can 
cleave ubiquitin from the substrate [54,56].  This provides a 
mechanism of control to prevent DUBs from indiscriminately removing 
ubiquitin from non-target proteins.  DUBs contain various domains, 
which consist of a catalytic, ubiquitin binding and protein-protein 
interaction domains to facilitate their binding of substrate proteins 
and recognizing ubiquitin for removal by hydrolysis [53,55,57]. 
    
Figure 6.  Ubiquitin specific protease mechanism of action.  Briefly, 
the His residue of the catalytic triad deprotonates the catalytic Cys 
residue in the triad.  The Cys residue then performs a nucleophilic 
attack on the Gly isopeptide, carbonyl carbon of the ubiquitin 
molecule bound to the side chain of the substrate Lys.  This forms a 
thiol-ubiquitin-carboxy-terminus intermediate.  Next, a water molecule 
performs a nucleophilic attack to release the ubiquitin molecule from 
the catalytic Cys and results in restoration of the USP’s thiol 
functional group (adapted from Eletr et al., 2014 [55]).  
 
 
Ubiquitin Cys His Lys 
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Four of the DUB families are thiol proteases (USP, OTU, UCH, Josephin), 
while the fifth family is composed of metalloproteases (JAMM).  The 
focus of this discussion will be on the thiol proteases and 
specifically those of the ubiquitin-specific proteases (USPs).  The 
thiol proteases contain a catalytic triad composed of a cysteine-
histidine-aspartic acid / asparagine (Cys-His-Asp/Asn).  The role of 
the Asp/Asn is to provide motivation to orient the His to coordinate 
the catalytic Cys for nucleophilic attack.  His deprotonates the 
catalytic Cys sulfhydryl group, which prepares the Cys for 
nucleophilic attack on the Gly isopeptide, carbonyl carbon of the 
ubiquitin molecule to be cleaved.  The nucleophilic attack by the Cys 
sulhydryl functional group results in an intermediate formed between 
the catalytic Cys thiol and the carboxy-terminus of ubiquitin bound to 
the side chain of the substrate Lys residue, also the protease’s His 
is returned to its natural state at this stage.  Next, a water 
molecule performs a nucleophilic attack on the thiol-ubiquitin-
carboxy-terminal intermediate, thus releasing the USP, restoring the 
catalyst to its natural state and releasing the ubiquitin-cleaved 
substrate [55] (Figure 6). 
 
Deubiquitinating Enzymes’ Roles in DNA Damage Repair 
It is well known that the DDR is regulated by many E1, E2 and E3 
ubiquitin protein cascades and these pathways must be regulated 
between an active and an inactive state.  DUBs provide the mechanism 
for negative regulation of the ubiquitin cascades by removing 
ubiquitin from substrate proteins involved in the DDR.  This section 
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will provide a brief overview on various DUBs and their implications 
in maintaining genome integrity, but is not an exhaustive discussion 
of DUBs regulating the DDR, a more comprehensive list can be found in 
Table 1 (p. 24). 
 
USP28 is involved in the CHK2-p53-PUMA ionizing radiation (IR) repair 
pathway.  One study showed that USP28 is responsible for stabilizing 
the protein levels of CHK2 and 53BP1 upon incurrence of IR DNA damage 
[58].  53BP1 interacts with p53 to promote cell cycle arrest.  USP28 
depletion was also shown to cause destabilization of various 
checkpoint regulators (MDC1, TOPBP1 and Claspin) as well as ATRIP and 
NBS1, whereby loss of these proteins lead to a reduction in p53 
dependent apoptosis and increased DNA damage induction as the DNA 
damage signal transduction is lost [58,59]. 
 
BRCC36, a metalloprotease in the JAMM family of DUBs, is a subunit of 
the BRCC complex (BRCA1 and BRCA2 Containing Complex) [58-60].  BRCC 
itself is an E3 ubiquitin ligase, however studies have shown that 
BRCC36 deubiquitinates histones H2A and H2AX, thus countering the 
activity of RNF8 and UBC13 [61-63].  The deubiquitination of these 
histones leads to the ablation of DSB, DNA damage signaling. 
 
USP44 is another DUB involved in deubiquitinating histone H2A and 
provides a mechanism of regulating RNF8 and RNF168 activity.  It 
possesses specificity for conjugated ubiquitin products of RNF168 at 
DSB foci, but does not affect the ubiquitination and chromatin 
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localization of RNF8 to histone H2A.  USP44 activity reduces RNF168 
chromatin localization, suggesting that USP44 regulates ubiquitinated 
H2A levels in the DSB repair pathway [64]. 
 
Table 1.  Discussion of various DUBS and their functions and specific 
substrates in the DDR pathway.  (Adapted from Jacq et al., (2013) 
[59]). 
                
 
USP1 and UAF1 Deubiquitinating Enzyme Complex 
Various DNA damage repair pathways are dependent on protein 
ubiquitination and deubiquitination; these pathways are regulated by 
E1, E2 and E3 ubiquitin cascades as well as deubiquitinating enzymes.  
USP1 and UAF1 form a heterodimer, deubiquitinating enzyme complex [79].  
USP1-UAF1 are responsible for deubiquitinating monoubiquitinated 
FANCD2 (FA pathway) and PCNA (TLS), hence USP1-UAF1 are regulators of 
DUB Family Substrates Function Repair Pathway References 
USP1 Ubiquitin-specific protease FANCD2, PCNA Regulates ICL repair  FA, TLS [59,62] 
       in the Fanconi Anemia pathway     
       and translesion synthesis     
USP2 Ubiquitin-specific protease MDM2, Cyclin D1 Regulates cell cycle progression Checkpoint [59,65,66] 
       at G1/S. Stabilizes MDM2 and     
       inhibits the p53 pathway     
USP4 Ubiquitin-specific protease ARF-BP1 Reduces p53 levels, inhibits  Checkpoint [59,67] 
       apoptosis and cell cycle arrest     
            
USP10 Ubiquitin-specific protease p53 Counters MDM2-mediated p53  DSB repair [59,68,69] 
       nuclear export, stabilizes and      
       activates p53     
USP11 Ubiquitin-specific protease Interacts with BRCA2 Promotes DNA repair via BRCA2 DSB repair [59,70,71] 
       pathway independent of BRCA2     
       deubiquitination     
USP24 Ubiquitin-specific protease DDB2 Promotes nucleotide excision NER [59,72] 
       repair, stabilize DDB2 (CRL4     
       E3 ligase) protein levels     
USP28 Ubiquitin-specific protease CHK2, 53BP1 Promotes IR repair via  HR and [58,59] 
       CHK2-p53-PUMA pathway  checkpoint   
            
USP44 Ubiquitin-specific protease H2A Regulates H2A ubiquitination, Checkpoint [59,64] 
       DNA damage signaling cascade,     
       counters RNF8/168 activity     
UCHL1 Ubiquitin C-terminal hydrolase p53 Promotes p53 dependent cell Checkpoint [59,73,74] 
       cycle arrest and apoptosis     
            
BRCC36 Metalloprotease (JAMM) H2A, H2AX Regulates histone ubiquitination, HR [59,61-63] 
       DNA damage signaling cascade,     
       counters RNF8 and UBC13 activity     
OTUB1 Ovarian tumor protease Binds UBE2N/UBC13  Inhibits RNF168 activity by  DSB repair [59,75,76] 
    (Allosteric regulator)  allosteric inhibition of RNF168's   
       E2 ubiquitin conjugating enzymes     
MYSM1 Metalloprotease (JAMM) H2A Inhibits H2A ubiquitination by DSB repair [59,77,78] 
       RNF8 an RNF168, mechanism not     
       fully understood     
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ICL repair and TLS [80-82].  It has been found that depletion of USP1 
and UAF1 leads to cellular sensitization to genotoxic agents 
(camptothecin, PARP inhibitor and mitomycin C) and an accrual of 
ubiquitinated FANCD2 and PCNA [79,82].  In concurrence with USP1 and 
UAF1 forming a heterodimer, USP1 and UAF1 depletion resulted in an 
epistatic relationship alluding to working in the same repair pathways 
[82]. 
 
UAF1 plays an important role in the heterodimer’s catalytic activity.  
It has been found that UAF1, the noncatalytic subunit of the USP1-UAF1 
DUB complex, stabilizes and activates USP1, which is the catalytic 
subunit of the DUB complex [79].  UAF1 possesses a WD40 repeat domain, 
comprised of eight WD sequences, in its N-terminus that binds USP1 and 
facilitates its proteolytic activity [82,83].  USP1 possesses very 
limited catalytic activity in the absence of UAF1, however, when bound 
to UAF1, USP1’s catalytic activity increases approximately 35-fold 
[83].  While USP1-UAF1 is known to regulate various DNA repair 
pathways, it is not fully understood through which mechanism(s) the 
DUB complex promotes genome stability.  
 
Figure 7.  A schematic of UAF1 wild type.  The N-terminus of UAF1 
contains eight WD sequences, comprising the WD40 repeat domain 
responsible for UAF1 interacting with USP1 and promoting its catalytic 
activity.  UAF1 contains two C-terminal SUMO-like domains SLD1 and 
SLD2 (adapted from Cohn et al., 2007 [83]). 
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RAD51AP1 Promotes D-loop Formation and DNA Repair 
As mentioned earlier the recombinase, RAD51, is vital for homologous 
recombination.  RAD51 is responsible for strand invasion during HR and 
does so by performing a homology search in the sister chromatid 
resulting in D-loop formation, thereafter downstream repair factors 
are recruited to complete HR [25].  RAD51AP1 (RAD51-associated protein 
1) interacts with RAD51 to promote its recombinase activity and has 
been shown to colocalize RAD51 at sites of DSBs [84,85].  RAD51AP1 
also possesses two DNA binding domains (N-terminus: residues 30-49, C-
terminus: residues 226-290), which facilitate RAD51 localization to 
sites of DNA damage during HR; the DNA binding domains are both 
indispensible for RAD51AP1 function in HR.   The DNA binding domains’ 
sequences were found to be rich in lysine and arginine residues, which 
are basic, thus facilitate the interaction between these domains and 
the negatively charged phosphodiester backbone of DNA [84].  Two 
studies have shown that RAD51AP1 binds RAD51 via its C-terminal 40 
residues [84,85].  RAD51AP1 has also been found to contain five 
phosphoserine residues [86-90] (Figure 8).   
 
Figure 8.  A schematic of the RAD51AP1 protein.  RAD51AP1 contains two 
DNA binding domains (residues 30-49 and 226-290), a RAD51 interaction 
region (residues 313-352) and five phosphoserines (residues 19, 21, 
120, 280 and 327).  Note: DBD1/2 (DNA binding domain), deleted in 
transcript variant 2 (ΔV2), phosphoserines (black vertical line). 
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Other studies have been conducted to assess the effects of RAD51AP1 on 
RAD51 recruitment to DSBs via immunofluorescence microscopy.  Both 
studies showed that RAD51AP1 colocalizes with RAD51, and that RAD51AP1 
foci are almost completely colocalized with RAD51.  When RAD51AP1 was 
depleted by RNAi, it was discovered that RAD51 was still able to form 
nuclear, foci bodies and that RAD51 foci formation is RAD51AP1 
independent [85,91]. 
 
RAD51AP1 has also been shown to have varying levels of expression in 
different cancer cell lines.  RAD51AP1 expression levels are increased 
in hepatocellular carcinoma and acute myeloid leukemia.  It is also 
suggested that there may exist a link between highly proliferating 
cancers and high expression of RAD51AP1.  Supporting this claim one 
study has shown that treating aggressive breast cancer with 
progesterone causes a decrease in RAD51AP1 expression levels [92].  
Interestingly, RAD51AP1 exhibits similar cell cycle-dependent 
expression levels to RAD51.  The same study showed that RAD51AP1 and 
RAD51 expression levels are low during G1 phase and as cells progress 
into S and G2/M phases, expression of these two proteins increases.   
To support the finding that RAD51AP1 and RAD51 expression and protein 
levels are similar to each other, a study was done and showed that 
under different DNA damaging agents, such as UV, γ-irradiation and 
doxorubicin, the protein levels remained constant in comparison to 
each other [92]. 
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CHAPTER THREE: INACTIVATING UBE2M IMPACTS THE DNA DAMAGE RESPONSE AND 
GENOME INTEGRITY INVOLVING MULTIPLE CULLIN LIGASES 
 
Rationale 
NEDD8 is a 76 amino acid ubiquitin-like molecule that possesses ~57% 
sequence similarity to ubiquitin and is involved in regulating many 
cellular pathways: DDR, transcriptional regulation, signal 
transduction and cell cycle progression [2-7].  NEDD8 is involved in a 
signaling cascade comprised of an E1, E2 and E3, those being an 
activating enzyme, conjugating enzyme and a ligase, respectively.  The 
scope of this paper is focused on the neddylation pathway of NEDD8 in 
activating Cullin Ring Ligases, whereby these CRLs promote genome 
stability by degrading various substrate proteins.  It should be noted 
however, that NEDD8 is involved in many DNA damage responses and some 
of those included nucleotide excision repair, homologous recombination, 
interstrand crosslink repair and histone neddylation to promote the 
DDR signaling cascade [1-5,93].  MLN4924, an investigational E1 NEDD8 
activating enzyme inhibitor, renders NEDD8 covalently bonded to NAE1, 
thus effectively inhibiting UBE2M, the E2 NEDD8 conjugating enzyme, 
from being charged with the NEDD8 molecule, thereby halting the 
neddylation pathway and CRL activation [21,22,94].  Due to the role of 
NEDD8 in regulating many cellular processes and specifically the DDR, 
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we investigated the inhibition of the NEDD8 pathway and its gross 
effects on maintaining genome stability.  We specifically focused on 
the effects of neddylation inhibition in the UBE2M pathway and abating 
activation of CRLs 1-4.  In the following discussion we will provide 
various mechanisms through which NEDD8 inhibition leads to genome 
instability involving the CRLs and this data supports claims of 
utilizing NEDD8 inhibition to sensitize cells to various genotoxic 
chemicals in treating various cancer types. 
 
Experimental Design and Methods1 
Cell Line, Plasmids and Chemical Reagents 
HeLa, HEK293T and U2OS cells were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% bovine serum and L-
glutamine.  HEY ovarian cancer cells (gift from Dr. Meera Nanjundan 
[95]; STR profiled) were cultured in RPMI supplemented with 10% bovine 
serum and L-glutamine.  HCT116 (WT and p21-/-; gift from Dr. Bert 
Vogelstein) cells were cultured in McCoy’s Medium supplemented with 
10% bovine serum and L-glutamine.  Cells were grown at 37°C in 5% CO2 
atmosphere.  Cells were maintained in respective media containing 
penicillin and streptomycin.  Cells were tested and found negative for 
mycoplasma.  UBE2M cDNA was cloned to pOZ-N retroviral expression 
vector.   
1.  Adapted from “Experimental Procedures in Inactivating UBE2M Impacts the 
DNA Damage Response and Genome Integrity Involving Multiple Cullin Ligases” 
by Cukras et al, 2014, PLoS One, 9(7), 3-5, Copr. 
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Site-directed mutagenesis was performed following the Stratagene 
QuikChange Site-Directed Mutagenesis protocol for UBE2M C111S and CUL2 
K689R.   pOZ-FLAG-HA-UBE2M and pCDNA-Myc3-CUL2 plasmids were used as 
templates  for site-directed mutagenesis, respectively.  MLN4924 was 
purchased from ActiveBiochem.  PARP inhibitor (ABT-888) and 
camptothecin were purchased from Selleck Chemicals. 
 
RNA Interference 
Cells were cultured in antibiotic/antimycotic free medium and 
transfected once with 20 nM siRNA using RNAiMAX (Invitrogen) reagent 
following the manufacturer’s protocol.  The following siRNA sequences 
were used: CUL1: 5’-AUUCCAGGCCAACAAACUGAGCUCC-3’, CUL2 #1: 5’-
GCCCUUACGUCAGUUGUAAAUUACA-3’, CUL2 #2: 5’-UUAGCAAGCAGUUCAGGUGCUUUGC-3’, 
CUL2 #3: 5’-AACCUAAUAAUUGUAUCUACA-3’, UBE2F #1: 5’-
CGGAGGGUUUCUGUGAGAGACAAAU-3’, UBE2F #2: 5’-UGAUGUAGUCAUCCACUUUAUUCCG-
3’, CDT1 #1: 5’-CCGCGCUUCAACGUGGAUGAA-3’, CDT1 #2: 5’-
CACCUGGUGGAUUCACAUUAA-3’, p21: 5’-AAGACCAUGUGGACCUGUCAC-3’, CLASPIN: 
5’-GACGCGAAGCAUCUUCCAAAUA-3’, IκB-α: 5’-AAGGGUGUACUUAUAUCCACA-3’, IκB-
β: 5’-CACGUGGCCGUUAUCCACAAA-3’, WEE1: 5’-CACUGGUAAAGCAUUCAGUAU-3’, 
NRF2: 5’-AAGGATTATGACTGTTAA-3’, BRCA1: 5’- CAGCAGTTTATTACTCACTAA-3’, 
CUL4A: 5’-AAAUGAAUCUUUAUACACCUGCAGG-3’, UBE2M #1: 5’-
GGGCUUCUACAAGAGUGGGAAGUUU-3’, UBE2M #2: 59-ACUCCAUAAUUUAUGGCCUGCAGUA- 
3’, CDT2 #1: 5’-CCGAGUCUACUGGGUAUAACA-3’, CDT2 #2: 5’-
CUGGGAUACCAGGUGCAACAA-3’.  A scrambled siRNA was used as control (All-
Star Negative, Qiagen). Lentiviral pLKO shRNA constructs were 
	   31	  
purchased from Sigma Aldrich.  Lentiviral vectors were transfected in 
HEK293T cells with helper plasmids.  48 hrs post-transfection, virus 
containing supernatant was harvested, filtered, and then used for 
infecting HEY, or HeLa cells.  The shRNA sequences are as follows: 
CUL4A: 5’-CCGGACTGTTTAGAACCCATATTATCTCGAGATAATATGGGTTCTAAACAGTTTTTTG-3’ 
UBE2M: 5’-CCGGCGATGGGAAATGAATTGGCTTCTCGAGAAGCCAATTCATTTCCCATCGTTTTT-3’ 
 
Western Blotting 
Cell extracts were run on an SDS-PAGE gel and then transferred to a 
PVDF membrane (Bio-Rad, Hercules, CA).  Membranes were probed with 
primary antibodies overnight at 4°C.  The membranes were then washed 
and incubated with either mouse or rabbit secondary antibody linked to 
horseradish peroxidase (Cell Signaling Technologies).  The bound 
antibodies were viewed with Pierce ECL Western Blotting Substrate 
(Thermo Scientific).  The following antibodies were used: α-CUL1, α-
CUL3, α-CUL4A, α-CHK1, α-CLASPIN, α-p21 and α-CDT1 rabbit polyclonal 
antibodies (Cell Signaling Technologies), α-CUL2 rabbit polyclonal 
(Novus Biologicals), α-γH2AX mouse monoclonal (Upstate), α-UBE2M and α-
Tubulin mouse monoclonal antibodies (Abcam), α-WEE1, α-RAD51 rabbit 
polyclonal and α-BRCA1 mouse monoclonal antibodies (Santa Cruz 
Biotechnology).  
 
Immunofluorescent Microscopy 
48~55 hrs after siRNA transfection (or shRNA transduction), cells were 
washed and pre-extracted with 0.25% Triton X-100 for 3 minutes and 
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then fixed in 4% paraformaldehyde for 10 min.  For the UBE2M rescue 
experiments, HEY cells were infected with UBE2M shRNA targeting 3’UTR 
and 48 hrs post-infection cells were transfected with pOZ-FLAG-HA-
UBE2M constructs.  ~48 hrs after, the cells were washed, fixed and 
pre-extracted with Triton buffer.  The fixed cells were incubated with 
primary antibodies against γH2AX (Upstate) and RAD51 (Santa Cruz 
Biotechnology) at 1:500, followed by incubation with Alexa Fluor 488-
anti-mouse (for γH2AX) or anti-rabbit (for RAD51) (Invitrogen).  
Vectashield mounting medium for fluorescence with DAPI (Vector 
Laboratories Inc, CA) was used to stain cellular nuclei.  Images were 
collected by a Zeiss Axiovert 200 microscope equipped with a Perkin 
Elmer ERS spinning disk confocal imager and a 63x/1.45NA oil objective 
using Volocity software (Perkin Elmer).  We counted 70-120 cells from 
each sample for generating statistical figures for γH2AX and RAD51 foci. 
 
GFP-based DNA Repair Assays 
A U2OS cell line expressing an integrated homologous recombination 
reporter DR-GFP (gift from Dr. Maria Jasin) has been described and a 
U2OS cell line expressing the NHEJ reporter was obtained from Dr. 
Jeremy Stark [96,97].  For NHEJ, the reporter contains a promoter that 
is separated from a GFP coding cassette by a puromycin resistance gene 
that is flanked by two I-SceI sites.  Once the puro gene is excised by 
NHEJ repair of the two I-SceI-induced DSBs, the promoter is joined to 
the rest of the expression cassette, leading to restoration of the GFP 
marker.  48 hrs post-I-SceI transfection, cells were harvested and 
analyzed via flow cytometry for recombination efficiency using a BD 
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Accuri C6 flow cytometer (BD Biosciences, Franklin Lakes, New Jersey). 
C-Flow software was used to analyze percent positive GFP cells 
relative to the total number of the transfected cells.  Approximately 
30 000 cells were counted from each sample. 
 
Cell Cycle Analysis 
HEY cells were synchronized at the G1-S interface by a double 
thymidine block.  On the first day, the cells were plated and 
incubated 24 hrs at 37°C in antibiotic/antimycotic free RPMI.  Cells 
were then treated with 2 mM thymidine for 18 hrs, followed by washing 
and release into fresh media for 8 hrs.  Cells were then treated with 
2 mM thymidine for 18 hrs and then released with two washouts of RPMI 
media.  Cells were then harvested at various times post-release (3-9 
hrs).  To analyze the effects of siRNAs for synchronous cell cycle, 
the cells were transfected with siRNAs on the first day when the cells 
were plated.  For studying the effects of MLN4924 on the cell cycle 
using a double thymidine block, the cells were treated with 0.3 µM 
MLN4924 for 6 hrs prior to the final release from thymidine.  For 
studying the effects of expressing CUL2 mutant on the cell cycle using 
a double thymidine block, all the procedures were left the same except 
that the plasmids were transfected during the first release period.  
Cells were trypsinized, resuspended in 0.5 mL PBS and pelleted, then 
washed in 0.5 mL PBS twice then fixed in 0.5 mL 70% ethanol and 
incubated at 4°C for 24 hrs.  Cells were then washed twice with PBS and 
resuspended in 0.44 mL of 50 µg/mL of propidium iodide in 1% Triton X-
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100 and 0.06 mL of 200 µg/µL RNAse was added and incubated at 22°C for 
1 hr.  Approximately 45 000 cells were counted via flow cytometry from 
each sample. 
 
Neutral Comet Assay 
Comet assays were conducted under neutral conditions to assess DNA 
double strand breakages following the Trevigen Neutral Comet Assay 
protocol.  Briefly, HEY cells were transfected with siRNA (CUL1-4A, 
UBE2M and UBE2F) or control siRNA (All-Star Negative) for 72 hrs.  
After which, cells were harvested and coated onto slides.  Cells were 
lysed in Trevigen Lysis Solution for 1 hr at 4°C.  Cells were then 
subjected to electrophoresis at 13 V for 35 min (1 V/cm lead-to-lead).  
Cells were stained for 30 min with 1:10000X SYBR Gold (Life 
Technologies, Carlsbad, CA).  50~100 cells were counted for generating 
statistical figures.  The comet tail moment, % Tail DNA and tail 
length were analyzed by Image J software. 
 
Cellular Growth Analysis 
Cells were transfected with siRNA (CDT2, UBE2M and CUL4A), control 
siRNA (All-Star Negative), or infected with virus containing the UBE2M 
shRNA (pLKO).  Varying the concentrations of camptothecin or a PARP 
inhibitor (ABT-888).  After 5~7 days, the cells were fixed in 10% 
acetic acid and 10% methanol solution, stained with crystal violet and 
dried colonies were dissolved and resuspended with Sorensen buffer, 
then the colorimetric intensity of each solution was quantified using 
Gen5 software on a Synergy 2 (BioTek, Winooski, VT) plate reader. 
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UBE2M Depletion Causes Genome Instability 
To assess whether UBE2M was implicated in maintaining genome stability, 
we performed shRNA knockdowns of UBE2M to test the effects on γH2AX 
foci formation.  γH2AX acts as a biomarker for sites of DSBs and 
becomes phosphorylated upon the occurrence of DNA damage (discussed on 
p. 14) [98,99].  When UBE2M was silenced by a 3’UTR shRNA, there was 
an induction in γH2AX foci formation, thus suggesting UBE2M is involved 
in genome maintenance (Figure 9).  
 
Figure 9.  UBE2M silencing results in genome instability.  UBE2M was 
depleted via 3’UTR shRNA knockdown and γH2AX foci were counted by 
immunofluorescent microscopy.  UBE2M was rescued by expression of 
UBE2M WT or the C111S mutant.  Western blot analysis shows knockdown 
efficiency and reconstitution of Flag-HA tagged UBE2M WT and C111S 
mutant (reprinted from “Inactivating UBE2M Impacts the DNA Damage 
Response and Genome Integrity Involving Multiple Cullin Ligases” by 
Cukras et al, 2014, PLoS One, 9(7), p. 2, Copr.) [101]. 
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We then performed a rescue experiment to determine whether the UBE2M 
knockdown phenotype could be reversed with UBE2M WT but not with the 
catalytically inactive UBE2M mutant (C111S).  The UBE2M-C111S mutant 
contains a serine at the cysteine residue (aa 111), which is 
responsible for covalently binding NEDD8 to UBE2M and thus cannot 
perpetuate the neddylation pathway to neddylate UBE2M’s Cullin 
substrates [100].  To validate that UBE2M silencing leads to increased 
genome instability, we performed a neutral comet assay to assess DSB 
formation as a result of UBE2M depletion; UBE2M knockdown led to 
increased DSBs compared to control.  To determine if UBE2M was the 
major NEDD8 E2 enzyme responsible for promoting genome stability we 
silenced UBE2F and determined it has little to no effect on genome 
stability (Figure 10). 
 
UBE2M Silencing Disrupts the DNA Damage Response 
Neddylation inhibitor MLN4924 has been previously shown to ablate the 
early onset DNA damage response [102,103].  Due to this effect of 
MLN4924 treatment on the DDR it was believed that the UBE2M 
neddylation pathway played a role in regulating the DDR, thus the 
basis of UBE2M silencing leading to genome instability.  UBE2M 
silencing, via shRNA knockdown, caused vast abatement of cellular 
proliferation in HEY cells.  Treating the cells with camptothecin 
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A.         B. 
 
Figure 10.  UBE2M depletion leads to increased DSBs detected by a 
neutral comet assay.  A.  siRNA knockdown of UBE2M in HEY cells, 72 
hrs post-transfection cells were prepared and DSBs detected by neutral 
comet assay.  B.  siRNA knockdown of UBE2F in HEY cells show minimal 
DSB formation via neutral comet assay (reprinted from “Inactivating 
UBE2M Impacts the DNA Damage Response and Genome Integrity Involving 
Multiple Cullin Ligases” by Cukras et al, 2014, PLoS One, 9(7), pp. 2, 
S1 Copr.) [101]. 
 
(a topoisomerase I inhibitor) exacerbated the effects of the UBE2M 
knockdown (Figure 11).  To determine whether UBE2M was involved in 
maintaining genome stability via HR, we treated cells with a PARP 
inhibitor (ABT-888) after UBE2M knockdown.  Cellular sensitization to 
PARP inhibitors is suggestive of a defect in HR and was observed in 
UBE2M depleted HEY cells (Figure 11).  Together these results suggest 
that UBE2M is involved in promoting the DDR and so doing by way of HR. 
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Figure 11. UBE2M knockdown causes cellular sensitization to DNA 
damaging agents implicating it in the DDR.  Cellular survival assays 
show UBE2M silencing causes HEY cell sensitization to camptothecin and 
PARP inhibitor, ABT-888 (reprinted from “Inactivating UBE2M Impacts 
the DNA Damage Response and Genome Integrity Involving Multiple Cullin 
Ligases” by Cukras et al, 2014, PLoS One, 9(7), pp. 4, S1 Copr.) [101]. 
 
RAD51 foci formation can be altered or abated in HR deficient cells.  
Treatment with MLN4924 causes a spontaneous increase in RAD51 and 
BRCA1 foci formation, which are hallmarks of DNA damage; this is 
consistent with a previous claim that MLN4924 induces spontaneous DNA 
damage (Figure 12A) [104].  MLN4924 treatment caused RAD51 foci to 
fail resolution over 24 hrs post-MLN4924 treatment.  UBE2M knockdown 
also caused a delay in RAD51 foci formation and also exhibited delayed 
RAD51 foci resolution over 8 hrs (Figure 12B, C).  To assess the role 
of UBE2M in the DDR a DR-GFP reporter assay was utilized to test the 
effects of UBE2M knockdown on HR efficiency.  An NHEJ (non-homologous
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A. 
   
B. 
 
C. 
       
 
Figure 12.  UBE2M inhibition abates the DDR.  A.  MLN4924 treatment 
(0.3 µM) in HeLa cells causes spontaneous BRCA1 and RAD51 foci 
formation, western blot shows efficiency of MLN4924 inhibition of 
neddylation pathway, * denotes neddylated Cullin.  B.  Time course 
assay assessing RAD51 foci formation and resolution with MLN4924 
treatment in HeLa.  C.  Time course assay assessing RAD51 foci 
formation and resolution with shRNA UBE2M knockdown in HeLa cells 
(reprinted from “Inactivating UBE2M Impacts the DNA Damage Response 
and Genome Integrity Involving Multiple Cullin Ligases” by Cukras et 
al, 2014, PLoS One, 9(7), p. 4 Copr.) [101]. 
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end joining) reporter system was used in conjunction to the HR 
reporter system.  UBE2M knockdown caused significant reduction in HR 
efficiency, approximately 50% decrease compared to control.  UBE2M 
knockdown was also performed in an NHEJ reporter cell line and did not 
cause any change in NHEJ efficiency compared to control (Figure 13).  
These results suggest UBE2M and the neddylation pathway are important 
for promoting genome stability and the DDR.  The results are also 
suggestive that UBE2M has a role in HR repair. 
 
Figure 13.  UBE2M promotes DNA repair via HR but not the NHEJ repair 
pathway.  UBE2M knockdown in DR-GFP HR and NHEJ reporter cell lines 
showed HR deficiency, while no decrease was detected in the NHEJ 
repair pathway (reprinted from “Inactivating UBE2M Impacts the DNA 
Damage Response and Genome Integrity Involving Multiple Cullin Ligases” 
by Cukras et al, 2014, PLoS One, 9(7), p. 4 Copr.) [101]. 
 
In various studies it has been claimed that inactivation of the NF-κB 
pathway leads to decreased HR efficiency by a reduction in RAD51 
recruitment to sites of DSBs.  NF-κB transcriptionally activates 
FANCD2 and BRCA1 expression [105,106].  Cullin 1 is a known E3 
ubiquitin ligase responsible for elevated NF-κB activation via 
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degradation of its substrate and inhibitor of the pathway, IκB [107].  
Due to UBE2M being a regulator of Cullin ligase activity, we wanted to 
determine whether MLN4924 and UBE2M silencing resulted in abatement of 
the NF-κB pathway.  To test this, we treated HeLa cells with siRNA 
against IκB and treated with MLN4924 and performed western blot 
analysis to ascertain the effects on FANCD2 and RAD51 protein levels 
(Figure 14).  No significant change in the protein levels were 
detected, thus suggesting UBE2M silencing does not operate through a 
major capacity in the NF-κB pathway. 
 
Figure 14.  UBE2M does not play a major role in the NF-κB pathway.  
HeLa cells were treated together with siRNAs against IκB-α and IκB-β 
and treated with 0.3 µM MLN4924 and probed for FANCD2 and RAD51.  
Cullin1 (CUL1) blot was used to show efficiency of MLN4924 neddylation 
inhibition (reprinted from “Inactivating UBE2M Impacts the DNA Damage 
Response and Genome Integrity Involving Multiple Cullin Ligases” by 
Cukras et al, 2014, PLoS One, 9(7), p. S1 Copr.) [101]. 
 
Cullin Ligases Arbitrate the Effects of UBE2M in Genome Maintenance 
Previously mentioned, UBE2M (E2 ubiquitin-conjugating enzyme) is 
responsible for neddylating Cullin (CUL) E3 ubiquitin ligases (CUL 1-
4) and their neddylation results in the Cullin Ring Ligases (CRLs) 
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activation [108].  To validate this claim, we performed siRNA 
knockdown of UBE2M and were able to show, via western blot analysis, 
UBE2M depletion ablated CUL 1-4 neddylated product formation (Figure 
15).  We then wanted to determine the effect of each Cullin (CUL 1- 4) 
on the DDR, using γH2AX foci as a biomarker for DSBs (Figure 16A). 
 
Figure 15.  UBE2M and Cullin ligase silencing affect genome stability.  
UBE2M knockdown was conducted with two siRNA in HeLa cells inhibits 
CUL 1-4 neddylation (reprinted from “Inactivating UBE2M Impacts the 
DNA Damage Response and Genome Integrity Involving Multiple Cullin 
Ligases” by Cukras et al, 2014, PLoS One, 9(7), p. S1 Copr.) [101]. 
 
CUl1, CUL2 and CUL4 (CUL4A was used throughout these experiments as 
CUL4B exhibited a weaker phenotype) silencing caused an induction of 
γH2AX foci formation, thus suggesting that these Cullins are important 
in maintaining genome stability.  To validate these findings, we 
performed a neutral comet assay and found that CUL1, CUL2 and CUL4 
increased the occurrence of DSB formation compared to control (Figure 
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16B).  CUL3 knockdown exhibited no effect on genome stability.  These 
results are suggestive that genome integrity is maintained by UBE2M 
via multiple Cullin pathways (CUL 1,2 and 4). 
A. 
   
B. 
 
Figure 16.  The effects of Cullin silencing on genome stability.  A.  
γH2AX foci formation was used to assess the effects of siRNA knockdown 
of CUL1-4 on genome integrity in HEY cells.  B.  Neutral comet assay 
using HEY cells to assess DSB formation caused by CUL1-4 siRNA 
knockdown (reprinted from “Inactivating UBE2M Impacts the DNA Damage 
Response and Genome Integrity Involving Multiple Cullin Ligases” by 
Cukras et al, 2014, PLoS One, 9(7), p. 6 Copr.) [101]. 
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Cullin 2 Depletion Impedes G1-S Transition 
As a result of our findings that UBE2M knockdown causes delayed RAD51 
foci formation (Figure 12C, p. 39), we suspected this may be due in 
part by delayed cell cycle progression.  Since HR is utilized in S-
phase and RAD51 is the hallmark protein of HR, we reasoned that the 
cell cycle may be retarded at the G1-S interface.  We first tested  
A. 
 
B. 
 
Figure 17.  UBE2M promotes the G1-S transition via CUL2 activation.  A.  
A double thymidine block in HEY cells treated with MLN4924 or siRNA 
against UBE2M impedes cell cycle progression.  B.  Double thymidine 
block in HEY cells treated with siRNA against CUL 1-4 shows CUL2 is 
responsible for G1-S progression.  The red vertical line denotes G1 
peak (2N) (reprinted from “Inactivating UBE2M Impacts the DNA Damage 
Response and Genome Integrity Involving Multiple Cullin Ligases” by 
Cukras et al, 2014, PLoS One, 9(7), p. 7 Copr.) [101]. 
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this hypothesis with synchronized cells treated with either MLN4924 or 
UBE2M knockdown and found that under both conditions the G1-S 
transition is delayed, suggesting protein neddylation is responsible 
for normal cell cycle progression into S-phase (Figure 17A).  Since 
UBE2M activates various Cullin ligases, we next tested to see which 
Cullin protein(s) were responsible for promoting the G1-S transition.  
We utilized synchronized HEY cells and treated them separately with 
siRNAs for CUL 1-4 to assess the effects of each Cullin on cell cycle 
progression.  CUL1 was already known to promote G1-S transition 
through degradation of p27 [109].  During our investigation, we did 
not observe any cell cycle delay due to CUL1 knockdown, but we did 
observe a significant delay in G1-S caused by CUL2 silencing and CUL4 
to a lesser extent (Figure 17B).  We performed a rescue experiment 
with CUL2 WT and CUL2 K689R NEDD8 mutant, which cannot be neddylated.  
We found that expression of CUL2 WT, but not the NEDD8 mutant, could 
partially rescue the G1-S delay (Figure 18A).  This result explicates 
the role of UBE2M-dependent neddylation of CUL2 and promoting normal 
cell cycle progression.  CUL2 has been shown to regulate p21 protein 
levels, which regulates actin based cell motility independent of cell 
cycle progression [110].  To investigate the role of p21 dependency of 
CUL2 in promoting a delayed G1-S transition, we performed the double 
thymidine block with siRNA knockdown of CUL2 in HCT116 WT and HCT116 
p21-/- cells (Figure 18B).  The G1-S delay was found to be p21 
independent, so we further investigated whether the CUL2, G1-S delay 
was responsible for impaired RAD51 foci recruitment.  We investigated 
the effects of CUL2 knockdown on RAD51 foci kinetics (Figure 18C). 
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A. 
   
 
B. 
 
 
C. 
 
Figure 18.  CUL2 neddylation is required for G1-S transition.  A.  
CUL2 WT and CUL K689R (ΔNEDD8) were expressed in HEY cells treated 
with siRNA CUL2 for the 3’UTR under a double thymidine block, CUL2 WT 
partially rescued G1-S arrest but not the NEDD8 mutant.  Western blot 
shows empty vector (EV) is not resistant to siRNA CUL2 and the 
exogenous DNA expression levels.  B.  Double thymidine block and siRNA 
knockdown of CUL2 was done in HCT116 WT and p21-/- cells.  CUL2 
knockdown G1-S delay phenotype is p21 independent.  C.  RAD51 foci 
formation kinetics were ascertained in HEY cells treated for siRNA 
CUL2 (reprinted from “Inactivating UBE2M Impacts the DNA Damage 
Response and Genome Integrity Involving Multiple Cullin Ligases” by 
Cukras et al, 2014, PLoS One, 9(7), p. 7 Copr.) [101]. 
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These results suggest RAD51 foci formation is delayed in part by a 
delayed G1-S transition caused by CUL2 deactivation. 
 
CUL4-CDT2 Depletion Causes G2-M Arrest and Increased RAD51 Foci 
Retention Affiliated With Defects in DNA Repair 
CUL4 silencing has been previously reported to cause G2-M arrest, due 
to CUL4-CDT2 being responsible for degradation of replication 
licensing factor CDT1, degradation of p21 (cyclin-dependent kinase 
inhibitor) and facilitating nuclear export of replication licensing 
factor CDC6  [111-113].  We observed this phenotype in the MLN4924 
treated, synchronized cells and with CUL4 knockdown (Figure 17A, B, p. 
44).  Due to the increased G2-M arrest previously mentioned, we 
believed this may be a main factor in the retention of RAD51 foci that 
failed to resolve with UBE2M knockdown (Figure 12C, p. 39).  We 
treated cells with siRNAs against CUL 2-4 and with camptothecin (CPT) 
and observed RAD51 foci kinetics.  CUL1 was omitted since it was 
highly toxic and provided too few foci to count.  The cells were 
treated with 0.5 µM CPT for ~18 hrs then the media was removed and 
fresh media added for the indicated time points (Figure 19).  CUL4 
knockdown showed elevated RAD51 foci 9 hrs after media change, while 
CUL2 showed an intermediate effect of RAD51 foci retention and finally 
CUL3 and control knockdowns showed unhindered RAD51 foci resolution.  
Previously mentioned, CUL4-CDT2 is responsible for degradation of CDT1, 
a replication licensing factor.  Increased CDT1 levels lead to 
rereplication and an increase in G2-M populations [114].  We validated 
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this by CDT2 shRNA knockdown (Figure 20).  We observed with CDT2 
knockdown, RAD51 foci were left unresolved over 24 hrs, much like the  
 
Figure 19.  CUL4 silencing leads to RAD51 foci retention.  HeLa cells 
were treated with siRNA against CUL 2-4 and treated for ~18 hrs with 
0.5 µM CPT.  Media was then changed to remove CPT for the designated 
time points (reprinted from “Inactivating UBE2M Impacts the DNA Damage 
Response and Genome Integrity Involving Multiple Cullin Ligases” by 
Cukras et al, 2014, PLoS One, 9(7), p. 9 Copr.) [101]. 
 
effects of UBE2M knockdown (Figure 12C, p. 39).  It has been 
previously reported that the CRL CUL4-CDT2 degrades CDT1 and p21; we 
wanted to test whether the CUL4-CDT2 knockdown phenotype could be 
rescued by CDT1 and p21 knockdown [111-113].  We found that with CDT1 
and p21 silencing the persistent RAD51 foci could be partially rescued 
in the CUL4 knockdown cells (Figure 21A).  These results suggest that 
CUL4-CDT2 knockdown result in increased G2-M populations and RAD51 
foci retention, which may be indicative of either active HR repair or 
defective HR repair.  RAD51 foci could signify defective HR because if 
repair does not follow to conclusion RAD51 may not be unloaded from 
the chromatin.  Cell survival assays were also conducted, which 
yielded repressed cellular proliferation (Figure 21B).  HEY cells were 
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treated with CUL4 and CDT2 siRNA and treated with 25 nm CPT.  
Decreased cell proliferation with CUL4 and CDT2 knockdown suggest that 
these cells exhibit an impaired DDR.   
   
Figure 20.  CDT2 knockdown causes impaired RAD51 foci resolution.  
CDT2 knockdown with shRNA was performed in HeLa cells for 72 hrs.  
RAD51 foci were counted at various time points after post-knockdown (+ 
72 hrs).  Western blot analysis shows efficiency of CDT2 knockdown 
with two different shRNA (reprinted from “Inactivating UBE2M Impacts 
the DNA Damage Response and Genome Integrity Involving Multiple Cullin 
Ligases” by Cukras et al, 2014, PLoS One, 9(7), p. 9 Copr.) [101]. 
 
We validated this claim by showing HR efficiency is also impaired with 
CUL4 and CDT2 knockdown (Figure 21C).  All of this data suggests that 
CUL4-CDT2 are important for regulating G2-M cell cycle progression and 
genome stability, while silencing these proteins is responsible for 
persistent RAD51 foci seen in UBE2M knockdown cells. 
 
CDT1 and p21 Are Partially Responsible for DNA Damage Induction 
Observed in UBE2M Depletion 
We investigated, via siRNA knockdowns, various Cullin substrates to 
purport potential mechanisms by which the Cullins confer an increased 
DDR found in UBE2M knockdown cells.  To render UBE2M inactive in cells, 
we used MLN4924 treatment and performed siRNA knockdowns for CHK1 and  
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A. 
 
 
B. 
 
 
C. 
 
Figure 21.  CUL4 silencing causes an impaired DDR and genome 
instability.  A.  shRNA knockdown of CUL4 induces RAD51 foci retention, 
which can be rescued by siRNA knockdown of either CDT1 or p21.  B. 
Cell survival assay shows CUL4 and CDT2 knockdown lead to HEY cell 
sensitization to CPT treatment.  C.  CUL4 and CDT2 knockdown cause 
impaired HR repair, but do not affect the NHEJ repair pathway 
(reprinted from “Inactivating UBE2M Impacts the DNA Damage Response 
and Genome Integrity Involving Multiple Cullin Ligases” by Cukras et 
al, 2014, PLoS One, 9(7), p. 9 Copr.) [101]. 
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BRCA1, both required for RAD51 foci recruitment.  We found that CHK1 
and BRCA1 knockdown led to reduced RAD51 foci, indicating that 
cellular checkpoints are necessary for an increased DDR and RAD51 foci 
recruitment and retention (Figure 22A).  We also tested various cell 
cycle and genome maintenance regulators that are known Cullin 
substrates (Figure 22B).  We discovered that, alongside CDT1 and p21, 
Claspin knockdown resulted in significant RAD51 foci reduction, again 
suggesting that cell cycle checkpoints are necessary for RAD51 foci 
retention.  All together, these results suggest that dysregulation of 
replication licensing factors and cell cycle regulators may be a root 
cause of eliciting a hyper-DDR and increased genome instability caused 
by the impaired neddylation pathway of UBE2M. 
 
Conclusion 
Our data has shown that the UBE2M neddylation pathway is vital for 
maintaining genome stability and normal cell cycle progression.  We 
have shown that UBE2M promotes the DDR, genome stability and cell 
cycle progression through multiple mechanisms involving various Cullin 
E3 ubiquitin ligases.  We have provided evidence that UBE2M is 
important in these pathways through multiple assays, importantly 
cellular survival assays showing UBE2M knockdown confers cellular 
sensitization to various genotoxic chemicals (PARPi and CPT).  A 
previous study has shown that UBE2M and RNF111 are responsible for 
neddylation of histone H4 [1].  This pathway then promotes the DDR via 
53BP1 and BRCA1 recruitment to the site of DNA damage.  This also 
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provides another mechanism through which UBE2M knockdown causes 
delayed RAD51 foci formation and a reduction in HR efficiency (Figure 
12C, p. 39 and Figure 13, p. 40).  We also discovered that CUL2 
promotes the G1-S transition of the cell cycle and CUL2 inactivation 
by UBE2M-deficiency leads to delayed RAD51 foci formation in S-phase.  
Despite delayed RAD51 recruitment, UBE2M knockdown also causes 
persistent RAD51 foci, which fail to be resolved at later time points 
compared to control (Figure 12B, C, p. 39).  Altogether, these data 
suggest that UBE2M silencing leads to an impaired DDR and cannot 
sufficiently resolve DNA damage.  Further investigation showed that 
CUL4 was the responsible substrate of UBE2M neddylation for RAD51 foci 
retention in cells treated with CPT (Figure 19, p. 48).  A study 
conducted in fission yeast, reported that CUL4-CDT2 is responsible for 
degradation of an inhibitor of a ribonucleotide reductase (RNR), which 
regulates nuclear pools of free dNTPs [115].  This is redolent of CDT2 
knockout cells causing a rise in inhibition of RNR, thus depleting the 
free dNTPs and rendering HR futile, since it is a DNA synthesis-
dependent pathway.  We have shown that CDT2 knockdown in HeLa cells 
confers CPT sensitivity, which is in line with this study’s claim, 
however it is unknown whether an RNR mechanism is present in mammalian 
cell lines.  We also suggest another hypothesis that CUL4-CDT2 
knockdown allows for free dNTP depletion and thus HR activity becomes 
impaired.  Another potential mechanism is through the regulation of 
FBH1, a helicase with anti-recombinase activity, by CUL4-CDT2 [116].  
FBH1 provides a negative-regulatory mechanism of HR. 
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Figure 22.  CDT1, p21 and Claspin partially rescue RAD51 foci caused 
by a hyper-DNA damage response.  A and B.  siRNA knockdown against 
various checkpoint regulator proteins in HEY cells treated with 
MLN4924, to inhibit the UBE2M neddylation pathway, showed the CDT1, 
p21 and Claspin are at least partially responsible for the heightened 
DDR in UBE2M-deficient cells (reprinted from “Inactivating UBE2M 
Impacts the DNA Damage Response and Genome Integrity Involving 
Multiple Cullin Ligases” by Cukras et al, 2014, PLoS One, 9(7), p. 10 
Copr.) [101]. 
 
The data presented provides support to the notion that UBE2M may be a 
potential therapeutic candidate for inducing DNA damage in various 
cancer cell lines where heightened Cullin expression has been reported 
[117-120].  Another study has reported that UBE2M expression levels 
are elevated in cancer cells induced with ionizing radiation DNA 
damage [121].  These reports suggest that UBE2M and the Cullins are 
important for cancer cell proliferation and survival.  Aside from the 
well known roles of CUL1 and CUL4 in cancer, we showed that CUL2 also 
plays a role in genome stability via the cell cycle (Figure 23).  
While it has been reported that CUL2 knockdown leads to p21 
stabilization, we did not observe p21-dependent cell cycle arrest in 
CUL2 knockdown cells [110].  Moreover, the CUL2 knockdown phenotype’s 
mechanism, responsible for the G1-S arrest, remains unknown. 
 
Finally, our data provides evidence that UBE2M is an important E2 
NEDD8 conjugating enzyme responsible for promoting genome stability 
via multiple mechanisms through neddylation and activation of various 
Cullin E3 ubiquitin ligases.  These data suggest that inactivation of 
the UBE2M neddylation pathway may provide multiple mechanisms and 
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pathways, dependent on Cullin inactivation, to produce new 
chemotherapeutic approaches in treating various types of cancer.  
 
 
Figure 23.  Model of the UBE2M neddylation repair pathway.  UBE2M 
neddylation and activation of Cullins 1, 2, and 4 is important to 
promote genome stability and proper cell cycle progression (reprinted 
from “Inactivating UBE2M Impacts the DNA Damage Response and Genome 
Integrity Involving Multiple Cullin Ligases” by Cukras et al, 2014, 
PLoS One, 9(7), p. 11 Copr.) [101].  
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CHAPTER FOUR: THE USP1-UAF1 DEUBIQUITINATING ENZYME COMPLEX PROMOTES 
DNA REPAIR BY STABILIZING RAD51AP1 (RAD51-ASSOCIATED PROTEIN 1) 
 
Rationale 
The USP1 and UAF1 heterodimer (USP1-UAF1) forms a deubiquitinating 
enzyme complex that is responsible for regulating genome stability by 
countering FANCD2 and PCNA monoubiquitination [80-82].  Importantly, 
USP1-UAF1 is known to regulate homologous recombination, however the 
exact mechanism through which the DUB complex promotes HR is not fully 
understood.  Utilizing mass spectrometry, we discovered a binding 
partner of UAF1 called RAD51AP1 (RAD51-associated protein 1).  As 
mentioned previously, RAD51AP1 is an important protein involved in HR, 
whereby it promotes RAD51’s recombinase activity by enhancing D-loop 
formation during strand invasion [84,85].  Upon discovery of the UAF1-
RAD51AP1 interaction, we performed preliminary investigations on the 
effects of USP1 and UAF1 involving protein levels of RAD51AP1, as DUB 
complexes are well known to regulate protein stability.  We were able 
to determine that USP1 and UAF1 promote the stabilization of RAD51AP1 
protein levels and since all three of these proteins are known to 
regulate homologous recombination, we propose that the interaction 
between the USP1-UAF1 DUB complex and RAD51AP1 facilitate genome 
stability and HR. 
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Experimental Design and Methods 
Cell Line, Plasmids and Chemical Reagents 
HeLa, HEK293T, U2OS and HEY cells were all cultured and maintained as 
described in Chapter 3 (p. 29).  RAD51AP1 cDNA was reverse transcribed 
following First Strand Synthesis protocol from NEB.  In short, 1 µg 
purified RNA was combined with 5 µM Oligo-dT primer and 2.5 µM dNTP.  
The mix is then heated for 3-5 minutes at 65°C then 10 U of RNAse 
inhibitor, Reaction buffer and 200 U M-MuLV Reverse Transcriptase were 
added and incubated for 1 hr at 42°C. Reverse transcription of RAD51AP1 
was performed from a HEY mRNA library (gift of Dr. Meera Nanjundan) 
and cloned into p3xFlag-CMV-10 expression vector.  Flag-HA-tagged UAF1 
WT was cloned into pOZ-N plasmid [83].  Flag-tagged UAF1 deletion 
constructs were expressed in pCDNA3.1 expression vector (Invitrogen).  
UAF1 deletion constructs bore the following amino acid deletions: 
UAF1-ΔWD2 and UAF1-ΔC, aa 65-104 and 635-677, respectively.  GFP-
tagged RAD51AP1 was expressed in pLEGFP-C1 plasmid (pLEGFP-C1 vector 
was a gift of Dr. Meera Nanjundan).  Cycloheximide and M2 agarose 
beads were purchased from Sigma Aldrich.  MG132 was purchased from 
Selleck Chemicals. 
 
RNA Interference 
Cells were prepared and transfected as described in Chapter 3 (p. 30).  
The following siRNA sequences were used: UAF1#1: 5’-
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AAUCAGCACAAGCAAGAUCCAUAUA-3’, UAF1#2: 5’-GGACCGAGAUUAUCUUUCAAUUGAA-3’, 
USP1#1: 5’-AGCUUCUGAAUAUAGAGCAUCUGAA-3’, USP1#2: 5’-
ACAGGCATTAATATTAGTGGA-3’ (3’UTR), RAD51AP1#1: 5’-
ATGGCATATGTCTCCGATTTA-3’, RAD51AP1#2: 5’-CAGCTTTACAAGGGTGTTTAT-3’,  
USP12: 5’-CCGATCATGGTAGTTGATTTA-3’, USP46: 5’-TAGGGAAATGTTTGTACTATA-3’, 
FANCD2: 5’-UUUGGAGGCAUCUUCUGUCAGGCUC-3’. siRNA obtained from 
Invitrogen. 
 
Western Blotting and Immunoprecipitation 
Cell extracts were prepared and western blot analysis was performed as 
described in Chapter 3 (p. 31).  The following antibodies were used: 
α-RAD51AP1 rabbit polyclonal (Abcam), α-Tubulin mouse monoclonal 
(Abcam), α-USP1, α-UAF1, α-53BP1, α-RPA70 rabbit polyclonal antibodies 
(Bethyl Laboratories), α-RAD51 rabbit polyclonal (Santa Cruz 
Biotechnology), α-FK2 mouse monoclonal (Millipore Corporation), α-Flag 
mouse monoclonal (Sigma Aldrich) and α-GFP rabbit monoclonal (Cell 
Signaling).  Immunoprecipitations were carried out as follows, HEK293T 
cells were seeded in 6 cm dishes and transfected with 4 µg DNA 24 hrs 
after seeding to transiently express Flag-tagged RAD51AP1 or UAF1 WT 
or UAF1 truncations using Lipofectamine 2000.  24 hrs post-
transfection cells were harvested and lysed in 0.5% NP-40 (50 mM Tris, 
100 mM NaCl at pH 7.0).  Lysates were then incubated in M2 agarose 
beads (Sigma Aldrich) for ~18 hrs at 4°C.  Beads were washed thrice 
with NP-40 buffer and prepared for western blot analysis. 
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Immunofluorescent Microscopy 
48 hrs post-siRNA transfection, HeLa or HEY cells were treated with 30 
µJ • m-2 UV irradiation at various times (0-6 hrs) pre-fixing, cells 
were then fixed per the previously mentioned method in Chapter 3 (pp. 
31-32).  p3xFlag—CMV-10-RAD51AP1 rescue experiments were conducted as 
follows, 24 hr post-siRNA transfection p3xFlag-CMV-10-RRAD51AP1 was 
transfected.  24 hrs post-DNA transfection (48 hrs post-siRNA 
transfection) cells were treated with 30 µJ • m-2 UV irradiation for 6 
hrs and then fixed.  Cells were then incubated with primary antibodies 
against RAD51 (Santa Cruz Biotechnology) at 1:500, followed by an 
incubation with Alexa Fluor 488-anti-rabbit (Invitrogen).  Cells were 
then mounted to coverslips and cellular nuclei stained using 
Vectashield mounting medium for fluorescence microscopy with DAPI 
(Vector Laboratories Inc, CA).  Images were collected by a Zeiss 
Axiovert 200 microscope equipped with a Perkin Elmer ERS spinning disk 
confocal imager and a 63x/1.45NA oil objective using Volocity software 
(Perkin Elmer). 
 
Cycloheximide Protein Stability Assay 
Cells were treated with siRNAs targeting USP1 and UAF1 for 48-72 hrs.  
10 µM cycloheximide was then added for various durations of time (0, 3, 
6 and 9 hrs).  After cycloheximide incubation cells were prepared for 
western blot analysis and probed for RAD51AP1 protein levels.  To test 
if RAD51AP1 is degraded by the proteasome, 10 µM MG132 was treated for 
the last 6 hrs of the 8 hr, 10 µM cycloheximide treatment. 
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GFP-based DNA Repair Assay 
DNA repair efficiency assay was prepared and conducted as discussed in 
Chapter 3 (pp. 32-34).  Co-depletions were performed by combining 
siRNAs against USP1 and FANCD2 at a total concentration of 20 nM (10 
nM of each siRNA).  The siRNA mix was incubated with transfection 
reagent RNAiMAX (Invitrogen). 
 
 
USP1 and UAF1 Silencing Causes Genome Instability and Delayed RAD51 
Foci Resolution 
A previous study has shown that USP1 and UAF1 are implicated in 
promoting homologous recombination and their depletion leads to a 
decrease in HR efficiency [122].  We independently validated this 
claim, and since the USP1-UAF1 heterodimer complex is believed to 
primarily regulate HR via monoubiquitinated FANCD2 deubiquitination, 
we performed a co-knockdown of USP1 and FANCD2 as well (Figure 24A).  
USP12 and USP46 serve as negative controls since it is known that UAF1 
also interacts with these two proteins, but they do not function in 
DNA repair.  Interestingly, we found that USP1 and FANCD2 co-depletion 
resulted in an exacerbated reduction of HR efficiency suggesting that 
USP1 may have a role in the HR repair pathway independent of FANCD2 
(Figure 24B).  As previously mentioned (p. 56), the precise mechanism 
through which USP1-UAF1 promote genome stability is, at present, not 
fully understood; we wanted to determine the mechanism through which 
USP1-UAF1 promote genome stability.  As mentioned earlier (p. 25), 
UAF1’s interaction with USP1 is paramount for USP1 to exhibit its 
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catalytic activity and stabilization [79].  Therefore, UAF1 silencing 
causes destabilization and inactivation of USP1, effectively acting as 
a USP1 knockdown, we investigated USP1-UAF1 DUB complex’s role in the 
DDR.  We silenced UAF1 via siRNA and treated cells with hydroxyurea 
(HU) then assessed foci formation of early onset DDR markers, 53BP1, 
RPA70 and FK2 ubiquitin chains (Figure 25).  We observed, with UAF1 
knockdown and HU treatment, foci formation of 53BP1, RPA70 and FK2 
chains.  These results suggest that the early onset DDR is not 
regulated by USP1-UAF1.  Due to an intact early DDR, we decided to 
perform time course studies of USP1 and UAF1 knockdown to investigate 
the effects they have on later time points in the DDR as measured by  
 
A.         B. 
   
 
Figure 24.  USP1-UAF1 depletion causes genome instability and reduced 
homologous recombination efficiency.  A. U2OS cells expressing a DR-
GFP reporter construct were treated with siRNA and HR efficiency was 
assessed.  B.  HR efficiency was determined for siRNA treated U2OS 
cells against USP1, FANCD2 and USP1 and FANCD2 co-depletion. 
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Figure 25.  USP1-UAF1 depletion reveals the DUB complex is not a 
regulator of the early onset DDR through canonical DNA double strand 
break response signaling.  HEY cells were treated with siRNA against 
UAF1 and probed for 53BP1, FK2 and RPA70 foci in the presence or 
absence of 2 mM HU treated for 24 hrs.  UAF1 knockdown does not 
disrupt these foci formation hence it does not regulate the early DDR. 
 
RAD51 foci kinetics.  We performed siRNA knockdown individually for 
USP1 and UAF1 (including two different sequences for UAF1 to exclude 
off-target effects) and treated the cells with 30 µJ • m-2 ultra violet 
irradiation (UV) then fixed the cells for immunofluorescent microscopy 
(IF) at various time points post-DNA damage to ascertain the quality 
of DNA repair (Figure 26).  We found that with both, USP1 and UAF1, 
knockdowns RAD51 foci had impaired rates of resolution compared to 
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control.  This data suggests that USP1-UAF1 regulate late stage DNA 
repair and their depletion leads to delayed RAD51 foci resolution. 
 
UAF1 Interacts with RAD51AP1 
An initial screen for binding partners of USP1 or UAF1, via liquid 
chromatograph mass spectrometry, revealed RAD51AP1 as a binding 
protein of UAF1 but not USP1 (Figure 27A).  To validate this finding, 
we performed a co-immunoprecipitation with Flag-tagged UAF1 and 
endogenous RAD51AP1 in HEK293T cells.  We were able to co-precipitate 
endogenous RAD51AP1, thus confirming UAF1 and RAD51AP1 as interacting 
proteins (Figure 27B).  We next wanted to evaluate various regions of 
UAF1 and their effects on promoting RAD51AP1 interaction.  UAF1 
contains two SUMO-like domains in its C-terminus that bind to SUMO-
interacting motifs (SIMs) (Figure 7, p. 25) [89].  UAF1 also interacts 
with USP1 via its second WD repeat.  We generated Flag-tagged UAF1 
truncation constructs containing deleted WD2 repeat and a C-terminal 
deletion removing the SLD2 domain (Figure 28A).  We wanted to test 
disrupting the USP1-UAF1 interaction with the WD2 truncation to test 
if this ablates UAF1-RAD51AP1 interaction.  It was suggested that 
RAD51AP1 contains an N-terminal SIM region and we wanted to test if 
the UAF1-RAD51AP1 interaction was dependent on an SLD2-SIM interaction 
of UAF1 and RAD51AP1, respectively [89].  Flag immunoprecipitations 
(IP) revealed that UAF1 WT was capable of interacting with RAD51AP1, 
while the SLD2 and WD2 mutants were not (Figure 28B).   
	   64	  
A. 
  
B. 
 
 
Figure 26.  USP1-UAF1 depletion causes a delayed DDR marked by RAD51 
foci retention.  A and B.  HEY cells were treated with siRNA against 
USP1 and UAF1 and then treated with 30 µJ • m-2 UV and cells were fixed 
for IF and probed for RAD51 foci to determine knockdown kinetic 
schemes showing USP1-UAF1 affects RAD51 foci resolution.  C.  siRNA 
against second UAF1 sequence and representative foci images. 
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A.        B. 
    
C.        D. 
   
 
Figure 27.  RAD51AP1 is a binding partner of UAF1.  A.  Liquid 
chromatography mass spectrometry (LC-MS) was performed on HeLa S3 
cells stably expressing Flag-HA-UAF1 or Flag-HA-USP1.  B.  Co-
immunoprecipitation of Flag-tagged UAF1 confirmed RAD51AP1 as a 
binding partner.  HEK293T cells transiently expressing Flag-tagged 
UAF1 prepared for anit-Flag immunoprecipitation with M2 agarose beads 
then western blot analysis was performed and probed for endogenous 
RAD51AP1.  C.  Flag-tagged RAD51AP1 IP confirms interaction with UAF1 
and USP1.  D.  Flag-tagged USP1 IP confirms RAD51AP1 interaction.  
Note: Immunoprecipitations were conducted with 1.5% Input loaded as 
control.  Red arrow is RAD51AP1 protein, * denotes non-specific bands. 
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These data suggest that UAF1 may present a folded structure bringing 
the WD2 region and SLD2 domain in close proximity of each other to 
facilitate the UAF1-RAD51AP1 interaction.  It remains to be validated 
whether there does exist an N-terminal SIM sequence and if it is 
responsible for the UAF1-RAD51AP1 interaction.   
A. 
 
 
B. 
 
 
Figure 28.  UAF1 requires its WD2 repeat and SLD2 domain for RAD51AP1 
interaction.  A.  Schematic of UAF1 truncations.  Note: SLD2 deletion 
(ΔC).  B.  Western blot confirmation of IP utilizing Flag-tagged UAF1 
truncations reveals UAF1 requires the WD2 repeat and SLD2 domain for 
RAD51AP1 interaction.  HEK293T cells were transfected with Flag-tagged 
UAF1 constructs and transiently expressed.  24 hrs post-transfection 
cells were prepared for anti-Flag IP.  Western blot probed for 
endogenous RAD51AP1. Note: Immunoprecipitation was conducted with 1.5% 
Input loaded as control.  Red arrow is RAD51AP1 protein, * denotes 
non-specific bands. 
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After confirming the UAF1-RAD51AP1 interaction we investigated the 
effects of RAD51AP1 silencing had on genome stability.  We treated HEY 
cells with siRNA against RAD51AP1 and 72 hrs post-transfection we 
treated the cells with 30 µJ • m-2 UV irradiation and fixed them at 
various times post-DNA damage to assess the DDR as marked by RAD51 
foci formation and resolution.  We observed a similar phenotype to 
that of USP1 and UAF1 knockdown time course experiments, whereby RAD51 
foci had a delayed rate of resolution compared to control (Figure 29).  
This data suggests that USP1, UAF1 and RAD51AP1 are working in the 
same repair pathway.  Next, we tested whether the USP1, UAF1 and 
RAD51AP1 knockdown phenotypes could be rescued with wild type RAD51AP1 
overexpression.  First, we performed siRNA knockdown of USP1, UAF1 and 
RAD51AP1 independently for 48 hrs.  We then transiently expressed wild 
type RAD51AP1 for 24 hrs and then treated the samples with UV-
irradiation.  6 hrs post-UV treatment, we fixed the samples for IF 
probing for RAD51 foci.  Our observations showed that overexpressing 
RAD51AP1 partially rescues the USP1, UAF1 and RAD51AP1 knockdown 
phenotypes compared to empty vector (Figure 30).  This data suggests 
that RAD51AP1 expression can compensate loss of function of USP1 and 
UAF1 and is important in promoting genome stability, specifically in 
the homologous recombination repair pathway. 
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A. 
 
 
B.        C. 
   
 
 
Figure 29.  RAD51AP1 silencing leads to an impaired DDR marked by 
delayed RAD51 foci resolution.  A and B.  HEY cells were treated with 
siRNA against RAD51AP1.  72 hrs post-transfection cells were treated 
with 30 µJ • m-2 UV and fixed at the denoted times for quantification 
by IF.  Cells were probed for RAD51 foci.  C.  Western blot confirming 
RAD51AP1 knockdown efficiency for two siRNA RAD51AP1 sequences.  The 
arrow denotes RAD51AP1 bands and others as non-specific bands detected 
by the RAD51AP1 antibody (Abcam). 
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Figure 30.  Wild type RAD51AP1 overexpression rescues impaired HR 
activity measured by RAD51 foci.  HeLa cells were treated with siRNA 
against USP1, UAF1 or RAD51AP1 for 48 hrs.  Cells were then 
transfected with wild type RAD51AP1 (p3xFlag-RAD51AP).  24 hrs post-
RAD51AP1 transfection, cells were treated with 30 µJ • m-2 UV and fixed 
6 hrs later for IF.  Cells were stained for RAD51 foci.  Note: ‘-
‘ denotes empty vector, ‘+’ treated with UV and the empty vector, ‘+ 
x3’ denotes treated with UV and RAD51AP1 overexpression.  
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UAF1 Acts as a Scaffold for USP1-UAF1 to Promote RAD51AP1 Interaction 
We further investigated the interaction of UAF1 and RAD51AP1.  
Mentioned earlier, UAF1 is a non-catalytic subunit of USP1 that 
promotes USP1 DUB activity [79].  We wanted to test the importance of 
UAF1 in regulating the USP1-UAF1 DUB complex interaction with RAD51AP1 
and exposing a potential role of UAF1 to mediate USP1-UAF1 interaction 
with RAD51AP1.  We used Flag-tagged RAD51AP1 and treated cells with 
siRNA against UAF1.  We then performed an anti-Flag IP and performed 
western blot analysis probing for USP1.  We discovered that with UAF1 
knockdown RAD51AP1 was incapable of co-precipitating USP1 (Figure 31A).  
To validate this result, we performed an anti-Flag IP with a Flag-
tagged USP1 construct, whilst silencing UAF1 and probing western blots 
for RAD51AP1 (Figure 31B).   
A.        B. 
    
Figure 31.  UAF1 is necessary for USP1-RAD51AP1 interaction.  HEK293T 
cells were transfected with UAF1 siRNA and 48 hrs post-siRNA 
transfection they were transfected with wild type Flag-tagged RAD51AP1 
(A.) or USP1 (B.).  24 hrs later cells were harvested and prepared for 
anti-Flag IP and then blotted for USP1 (A.) or RAD51AP1 (B.).  Note: 
RAD51AP1 is denoted as AP1 in the above western blots.  
Immunoprecipitations were conducted with 1.5% Input loaded as control. 
Red arrow is RAD51AP1 protein, * denotes non-specific bands. x denotes 
USP1 autocleavage product [88]. 
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We were able to replicate our finding, thus showing that UAF1 is 
necessary for USP1-RAD51AP1 interaction.  These data suggest that UAF1 
functions as a scaffold protein of the USP1-UAF1 DUB complex and 
facilitates the interaction between USP1 and RAD51AP1.  Discovery of 
the importance of UAF1 acting as a scaffold protein prompted further 
investigation and characterization of the UAF1-RAD51AP1 interaction.  
We generated various truncated Flag-tagged RAD51AP1 constructs and 
performed anti-Flag IPs to assess each truncation’s ability to co-
precipitate endogenous UAF1 (Figure 32).  The truncated RAD51AP1 
constructs were transiently expressed in HEK293T cells and harvested 
24 hrs post-transfection.  The cells were then prepared for 
immunoprecipitation using anti-Flag beads and the IPs were performed 
between 5-18 hrs to detect endogenous UAF1 interaction with Flag-
tagged RAD51AP1 by western blot analysis.  Western blots were probed 
for Flag (RAD51AP1).  According to our data we determined that the 
region spanning amino acid residues 97-125 is responsible for the 
interaction between UAF1 and RAD51AP1.  
 
The USP1-UAF1 DUB Complex Facilitates RAD51AP1 Protein Stability 
DUB proteins are well known to provide a means of protein 
stabilization to their various substrate proteins.  DUBs are 
responsible for deubiquitination of substrate proteins, which protects 
these substrates from degradation by the proteasome, hence the 
substrate protein level becomes stabilized.  We wanted to investigate 
the effects USP1-UAF1 had on stabilizing RAD51AP1 protein levels.  To  
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A. 
 
B.       C. 
   
D. 
 
Figure 32.  The UAF1-RAD51AP1 interaction is confined in a region of 
28 amino acids.  A.  Graphical representation of RAD51AP1 truncation 
constructs to determine the region necessary to interact with UAF1.  
‘+’ sign denotes positive interaction with UAF1.  Note: DBD1/2 (DNA 
binding domain), deleted in transcript variant 2 (ΔV2), phosphoserines 
(black vertical line).  B, C and D.  HEK293T cells transiently 
expressed Flag-tagged RAD51AP1 truncation constructs.  24 hrs post-DNA 
transfection cells were harvested and prepared for IP.  5-18 hrs post-
IP cells were prepared for western blot analysis and probed for 
endogenous UAF1.  Note: Immunoprecipitations were conducted with 1.5% 
Input loaded as control. x denotes 25 kDa band is an Ab light chain. 
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determine the effects USP1-UAF1 has on RAD51AP1 stability we utilized 
a cycloheximide chase assay.  Cells were transfected with siRNA 
against USP1 and UAF1.  72 hrs post-siRNA transfection, cell were 
treated with 10 µM cycloheximide (CHX), to halt translation and to 
observe RAD51AP1 half-life.  Cells were then fixed at various CHX 
treatment durations to assess the effects of USP1 and UAF1 knockdown 
on RAD51AP1 protein stability.  We found that when cells were depleted 
in USP1 or UAF1 RAD51AP1 became vastly destabilized compared to 
control (Figure 33).  To validate this finding and to exclude any cell 
line specific phenotypes, we conducted the CHX assay in various cell 
lines (HeLa, HEY and HCT116) and we found that each exhibited the same 
phenotype.  To exclude siRNA off-target effects we also treated cells 
with different siRNA sequences for USP1 and UAF1.  Again, the same 
phenotype was observed.  These data suggest that USP1 and UAF1 are 
important in promoting RAD51AP1 protein stability.  Since USP1 and 
UAF1 form a DUB complex, we wanted to test whether RAD51AP1 was 
stabilized and protected from proteasomal degradation by being 
deubiquitinated by USP-UAF1.  We initially tested whether treating 
cells with a proteasome inhibitor, MG132, would stabilize RAD51AP1 
protein levels.  HEY cells were treated with CHX for 4 and 8 hrs as 
well as treated with 10 µM MG132 for 6 hrs.  We observed that RAD51AP1 
protein levels became stabilized with MG132 treatment (Figure 34).  
This data suggests that RAD51AP1 is degraded by the proteasome. 
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Figure 33.  USP1 and UAF1 stabilize RAD51AP1.  A, B, C.  HeLa, HEY and 
HCT116 cells were treated with siRNA against USP1 and UAF1 for 72 hrs, 
and with 10 µM CHX for the time points mentioned (Hrs).  Cells were 
then prepared for western blot analysis and probed for RAD51AP1 
protein levels.  D.  siRNAs for USP1 and UAF1 were used in HeLa cells.  
Note: Red arrow is RAD51AP1 protein (marked by knockdown in A.), * 
denotes non-specific bands.  Band intensities quantified in ImageJ. 
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Figure 34.  RAD51AP1 is stabilized by MG132 treatment.  HEY cells were 
treated with CHX for 4 and 8 hrs and treated with 10 µM MG132 for 6 
hrs.  Cells were then harvested and prepared for western blot analysis 
and probed for RAD51AP1.  Note: Red arrow is RAD51AP1 protein (marked 
by knockdown in A.), * denotes non-specific bands. 
 
After observing that RAD51AP1 is stabilized with treatment by MG132 we 
wanted to determine whether USP1 is the sole DUB responsible for 
RAD51AP1 stability.  Since UAF1 is a subunit of various DUB enzymes, 
USP1, USP12 and USP46, we wanted to explicate which DUB or DUBs was 
UAF1 working through to promote RAD51AP1 stability [79].  To test this, 
we performed a co-knockdown of USP12 and USP46 in HEY cells.  72 hrs 
post-transfection the cells were treated with 10 µM CHX for 4 and 8 
hrs to assess protein half-lives.  The cells were then harvested and 
prepared for western blot analysis and probed for RAD51AP1.  We 
observed that with USP12 and USP46 knockdown there was no significant 
change in RAD51AP1 protein levels as compared to control (Figure 35).  
This data suggests that UAF1 is working exclusively with USP1 to 
stabilize RAD51AP1. 
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Figure 35.  UAF1 facilitates RAD51AP1 stability through USP1.  HEY 
cells were treated with siRNA against USP12 and USP46 for 72 hrs.  
Cells were then treated with 10 µM CHX for 4 and 8 hrs.  Cells were 
prepared for western blot analysis and probed for RAD51AP1.  Note: Red 
arrow is RAD51AP1 protein (marked by knockdown in A.), * denotes non-
specific bands. 
 
Conclusion and Future Directions 
The USP-UAF1 deubiquitinating complex has been well studied and is 
known to promote homologous recombination repair.  USP1-UAF1 DUB 
complex is known to deubiquitinate various substrate proteins, namely 
FANCD2 of the Fanconi Anemia pathway and PCNA of the Translesion 
Synthesis pathway [80-82].  Interestingly, knockdown of either USP1 or 
UAF1 results in genome instability and the reason for this is not 
completely understood.  It is possible that the role of USP1-UAF1 in 
the DDR is more expansive than previously thought and mediates various 
repair pathways via undisclosed binding proteins alongside FANCD2 and 
PCNA dependent repair mechanisms [122].  Our data presents a possible 
mechanism that promotes HR in congruence with USP1-UAF1-dependent 
repair pathways.  We have shown that RAD51AP1 interacts with the DUB 
complex via its interaction with UAF1.  We have shown that USP1 also 
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interacts with RAD51AP1, but this is dependent on the presence of UAF1, 
thus suggesting UAF1 acts as a scaffold protein. 
 
The interaction of USP1-UAF1 with RAD51AP1 provides further 
understanding of how the DUB complex promotes HR.  We have shown that 
the early onset DDR is not affected with the absence of USP1 and UAF1, 
but the late stage DDR is impaired.  We have shown that with USP1, 
UAF1 and RAD51AP1 depletion, cells exhibit reduced HR repair as marked 
by delayed RAD51 foci resolution (Figure 26, p. 63 and Figure 29, 
p.67).  This is an important finding because it is known that RAD51AP1 
is implicated in homologous recombination by promoting RAD51 
recombinase activity and RAD51-mediated D-loop formation at sites of 
DNA damage [84,85].  Our data provides evidence that USP1-UAF1 
stabilize RAD51AP1 protein levels [Figure 33, p. 73].  This finding 
suggests that USP1-UAF1 promote RAD51AP1-mediated HR by stabilizing it.  
This also provides a mechanism through which USP1-UAF1 promote DNA 
repair as USP1 or UAF1 depletion leads to reduced HR efficiency it is 
possible this is in part due to RAD51AP1 destabilization. 
 
Moving forward, we are set to further investigate the UAF1-RAD51AP1 
protein-protein interaction.  We have found a region of RAD51AP1, 
consisting of 28 amino acids, that is responsible for the UAF1-
RAD51AP1 interaction.  We have investigated various structural 
predictions of RAD51AP1, based on its primary amino acid sequence, to 
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determine potential binding residues and these predictions have 
revealed the 28 amino acid stretch lies in a disordered region.  We 
therefore, will continue to make various truncation constructs for 
immunoprecipitation to reduce the interaction region to the minimum 
size possible.  At this point we will perform point-mutagenesis on the 
remaining residues to determine the absolute minimum required residues 
necessary for the UAF1-RAD51AP1 interaction.   
 
Upon acquisition of the minimum required residues, we will perform 
various rescue experiments to show that wild type RAD51AP1 promotes HR 
and genome stability, whereas the mutant does not.  We will perform 
CHX analysis (similar to that in Figure 33, p. 73) to show that the 
UAF1-interaction deficient RAD51AP1 (ΔUAF1) is greatly destabilized, 
akin to the USP1 or UAF1 knockdown phenotype, compared to wild type 
RAD51AP1 (RAD51AP1 WT).  Cells will be treated with 3’UTR siRNA 
against endogenous RAD51AP1 for 48 hrs.  48 hrs post-siRNA 
transfection, cells will be reconstituted with either RAD51AP1 WT or 
ΔUAF1 for 24 hrs.  Afterward cells will be treated with 10 µM CHX over 
9 hrs and then prepared for western blot analysis to determine 
RAD51AP1 protein levels of ΔUAF1 compared to RAD51AP1 WT.  This data 
would suggest that the interaction between UAF1 and RAD51AP1 is 
paramount for RAD51AP1 stabilization.  We would also show in a 
clonogenic assay that RAD51AP1 WT rescues drug sensitivity to RAD51AP1 
depleted cells, whereas ΔUAF1 does not rescue the defects of RAD51AP1 
knockdown in sensitized cells.  This experiment will be conducted in 
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HeLa cells, stably expressing RAD51AP1 WT or ΔUAF1, and endogenous 
RAD51AP1 will be depleted via a 3’UTR siRNA for 48 hrs.  72 hrs post 
transfection the cells will be treated with multiple genotoxic agents 
and at varying concentrations.  This experiment can also be conducted 
with co-knockdowns of endogenous RAD51AP1 (3’UTR) and USP1 or UAF1.  
We expect to observe that RAD51AP1 WT rescues RAD51AP1 knockdown 
phenotype (sensitivity to drugs) and ΔUAF1 confers sensitivity to the 
drugs.  This data suggests that the UAF1-RAD51AP1 interaction is 
necessary to promote genome stability and maintenance.  Lastly, we can 
conduct experiments to rescue USP1, UAF1 and RAD51AP1 knockdown 
phenotypes as marked by RAD51 foci kinetics (Figure 26, p. 63 and 
Figure 29, p.67).  We showed that USP1, UAF1 and RAD51AP1 knockdown 
result in delayed RAD51 foci resolution.  To rescue these phenotypes 
we will knockdown USP1, UAF1 or RAD51AP1 (3’UTR) in HeLa cells stably 
expressing RAD51AP1 WT or ΔUAF1 for 72 hrs.  72 hrs post-knockdown we 
will treat the cells with 30 µJ • m-2 UV and allow cells to repair the 
induced damage over 6 hrs.  At various times during DNA damage 
resolution, cells will be fixed and prepared for IF.  Cells will be 
probed for RAD51 foci.  We expect to see that RAD51AP1 WT is able to 
rescue USP1, UAF1 and endogenous RAD51AP1 depletion phenotypes (i.e. 
RAD51 foci resolution matches that of control foci kinetics).  On the 
other hand, ΔUAF1 will not be able to rescue the knockdown phenotypes, 
thus suggesting that the UAF1-RAD51AP1 interaction is indeed necessary 
to promote DNA repair via homologous recombination. 
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Finally, we will investigate the possibility that RAD51AP1 is 
ubiquitinated and degraded by the proteasome.  As discussed earlier, 
RAD51AP1 protein levels become stabilized with treatment of the 
proteasome inhibitor MG132 (Figure 34, p. 74).  We believe that 
RAD51AP1 is degraded by the proteasome and stabilized by USP1-UAF1 
deubiquitination.  To date we have not been able to show that RAD51AP1 
is ubiquitinated by in vivo ubiquitination assays or that with USP1 or 
UAF1 knockdown RAD51AP1 is rendered hyper-ubiquitinated.  This 
suggests either experimental error has made this phenotype elusive or 
that USP1-UAF1 promote RAD51AP1 stability via a non-catalytic 
mechanism independent of deubiquitination.  We will reinvestigate this 
again once we find a UAF1-interaction deficient RAD51AP1 mutant.  We 
can then perform in vivo ubiquitination assays with RAD51AP1 WT and 
ΔUAF1 to determine any difference in RAD51AP1 ubiquitination levels.  
Should we observe increased ubiquitination of RAD51AP1 in the ΔUAF1 
mutant, we can conclude that the USP1-UAF1 DUB complex promotes 
RAD51AP1 protein stability by deubiquitinating RAD51AP. 
 
All together our research will explicate the role and necessity of the 
UAF1-RAD51AP1 interaction in promoting genomic integrity.  Based on 
our data we propose a model through which USP1 and UAF1 promote genome 
stability (Figure 36).  We propose that RAD51AP1 promotes HR late in 
the DDR and that RAD51AP1 does not affect the early onset DDR.  It is 
possible that RAD51AP1, alongside its function to recruit RAD51 to 
sites of DNA damage, facilitates the roles of repair proteins such as 
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FANCD2, BRCA1/2 and PCNA.  This notion provides reason alone to 
further investigate the role of RAD51AP1 in promoting genome stability 
independent of or at least downstream of its interaction with USP1-
UAF1.  We have produced evidence that the interaction between USP1-
UAF1 with RAD51AP1 promotes RAD51AP1 protein stability and we will 
show that the interaction promotes the DDR.  We have shown that USP1 
and UAF1 are important in promoting genome stability and while the 
mechanism to date remains unknown, we have provided evidence of a new 
mechanism that promotes the DUB’s function in HR and maintaining 
genome stability. 
 
Figure 36.  Proposed model of USP1-UAF1 promoting genome stability via 
their interaction with RAD51AP1.  This model shows that USP1-UAF1 
promoted genome maintenance by interacting with RAD51AP1 downstream of 
early onset DDR repair proteins.  We suggest that USP1-UAF1 promote 
the HR repair by coordinating multiple steps, namely deubiquitination 
of FANCD2-FANCI and promoting stability of RAD51AP1.  It remains to be 
determined whether RAD51AP1 are functionally connected to FANCD2. 
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